BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649-2651. [PMID: 18550886 DOI: 10.1056/nejmc0708819] [Cited by in Crossref: 1369] [Cited by in F6Publishing: 296] [Article Influence: 97.8] [Reference Citation Analysis]
Number Citing Articles
1 Spinks J. A clue on the face... BMJ Case Rep 2010;2010:bcr1220092587. [PMID: 22736736 DOI: 10.1136/bcr.12.2009.2587] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Kiene H, Hamre HJ, Kienle GS. In support of clinical case reports: a system of causality assessment. Glob Adv Health Med 2013;2:64-75. [PMID: 24416665 DOI: 10.7453/gahmj.2012.061] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
3 Krstulovic C, Ibañez-alcañiz I, Alamar-velázquez A, López-andreu JA, Evoli-buselli M. Fast response of subglottic haemangiomas to propranolol. Anales de Pediatría (English Edition) 2016;85:210-1. [DOI: 10.1016/j.anpede.2015.11.013] [Reference Citation Analysis]
4 Veras TN, Benvenutti RC, Hornburg G, Schner AM. Subglottic hemangiome in childhood. Braz J Otorhinolaryngol 2012;78:143. [PMID: 22392255 DOI: 10.1590/s1808-86942012000100025] [Reference Citation Analysis]
5 Chang TC, Estes R. Beta blocker treatment of infantile conjunctival hemangiomas--observations from 2 cases. J AAPOS 2014;18:80-2. [PMID: 24568991 DOI: 10.1016/j.jaapos.2013.09.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Cuesta AM, Albiñana V, Gallardo-Vara E, Recio-Poveda L, de Rojas-P I, de Las Heras KVG, Aguirre DT, Botella LM. The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease. Sci Rep 2019;9:10062. [PMID: 31296894 DOI: 10.1038/s41598-019-46448-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ji Y, Wang Q, Chen S, Xiang B, Xu Z, Li Y, Zhong L, Jiang X, Yang X. Oral atenolol therapy for proliferating infantile hemangioma: A prospective study. Medicine (Baltimore) 2016;95:e3908. [PMID: 27310994 DOI: 10.1097/MD.0000000000003908] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 5.4] [Reference Citation Analysis]
8 Wang N, Chen H, Teng Y, Ding X, Wu H, Jin X. Artesunate inhibits proliferation and invasion of mouse hemangioendothelioma cells in vitro and of tumor growth in vivo. Oncol Lett 2017;14:6170-6. [PMID: 29113263 DOI: 10.3892/ol.2017.6986] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
9 Farzad Hosseini, Bahmaei M, Davallo M. Electrochemical Determination of Propranolol, Acetaminophen and Folic Acid in Urine, and Human Plasma Using Cu2O–CuO/rGO/CPE. Russ J Electrochem 2021;57:357-74. [DOI: 10.1134/s1023193521040054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kowalska M, Dębek W, Matuszczak E. Infantile Hemangiomas: An Update on Pathogenesis and Treatment. J Clin Med 2021;10:4631. [PMID: 34682753 DOI: 10.3390/jcm10204631] [Reference Citation Analysis]
11 Gupta A, Verma A, Dhua A, Bhatnagar V. Vascular Anomalies: A Pediatric Surgeon's Perspective. Indian J Pediatr 2017;84:612-7. [PMID: 28466404 DOI: 10.1007/s12098-017-2355-8] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Nakayama H, Huang L, Kelly RP, Oudenaarden CR, Dagher A, Hofmann NA, Moses MA, Bischoff J, Klagsbrun M. Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins. Biochem Biophys Res Commun 2015;464:126-32. [PMID: 26086095 DOI: 10.1016/j.bbrc.2015.06.087] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
13 De Giorgi V, Geppetti P, Lupi C, Benemei S. The Role of β-Blockers in Melanoma. J Neuroimmune Pharmacol 2020;15:17-26. [PMID: 31482435 DOI: 10.1007/s11481-019-09876-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Ahmed AE, Abo El-Magd EA, Hasan GM, El-Asheer OM. A comparative study of propranolol versus silver nitrate cautery in the treatment of recurrent primary epistaxis in children. Adolesc Health Med Ther 2015;6:165-70. [PMID: 26457059 DOI: 10.2147/AHMT.S84806] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
15 Ebert AK. [Pathological findings in the scrotum and testis and initial diagnostic management]. Urologe A 2010;49:1476-80, 1482-4. [PMID: 21107803 DOI: 10.1007/s00120-010-2462-x] [Reference Citation Analysis]
16 Park HJ, Lee SY, Rho MH, Jung HL. Ultrasound and MRI findings as predictors of propranolol therapy response in patients with infantile hemangioma. PLoS One 2021;16:e0247505. [PMID: 33690675 DOI: 10.1371/journal.pone.0247505] [Reference Citation Analysis]
17 Bruno G, Cencetti F, Pini A, Tondo A, Cuzzubbo D, Fontani F, Strinna V, Buccoliero AM, Casazza G, Donati C, Filippi L, Bruni P, Favre C, Calvani M. β3-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P2 modulation. Oncogene 2020;39:368-84. [PMID: 31477835 DOI: 10.1038/s41388-019-0993-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
18 Li SB, Xu GQ, Gao F, Huo R. Treatment with propranolol for infantile hemangiomas: A case series of 106 infants. Exp Ther Med 2015;10:51-4. [PMID: 26170911 DOI: 10.3892/etm.2015.2485] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Ji Y, Chen S, Wang Q, Xiang B, Xu Z, Zhong L, Yang K, Lu G, Qiu L. Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management. Sci Rep 2018;8:4264. [PMID: 29523832 DOI: 10.1038/s41598-018-22787-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
20 Prasad A, Sinha AK, Kumar B, Prasad A, Kumari M. Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study. Pan Afr Med J 2019;32:155. [PMID: 31303926 DOI: 10.11604/pamj.2019.32.155.16760] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Pasquier E, Street J, Pouchy C, Carre M, Gifford AJ, Murray J, Norris MD, Trahair T, Andre N, Kavallaris M. β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma. Br J Cancer. 2013;108:2485-2494. [PMID: 23695022 DOI: 10.1038/bjc.2013.205] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 10.4] [Reference Citation Analysis]
22 Fernandez-Pineda I, Williams R, Ortega-Laureano L, Jones R. Cardiovascular drugs in the treatment of infantile hemangioma. World J Cardiol 2016; 8(1): 74-80 [PMID: 26839658 DOI: 10.4330/wjc.v8.i1.74] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Yuan W, Wang X. Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation. Biomed Res Int 2021;2021:6636891. [PMID: 33575332 DOI: 10.1155/2021/6636891] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Heinhuis KM, IJzerman NS, Koenen AM, van der Graaf WTA, Haas RL, Beijnen JH, Huitema ADR, van Houdt WJ, Steeghs N. PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma-a proof of principle study. BMJ Open 2020;10:e039449. [PMID: 32912994 DOI: 10.1136/bmjopen-2020-039449] [Reference Citation Analysis]
25 Nair SC. Vascular Anomalies of the Head and Neck Region. J Maxillofac Oral Surg 2018;17:1-12. [PMID: 29382987 DOI: 10.1007/s12663-017-1063-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
26 Dupuis-Girod S, Pitiot V, Bergerot C, Fargeton AE, Beaudoin M, Decullier E, Bréant V, Colombet B, Philouze P, Faure F, Letievant JC. Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial. Sci Rep 2019;9:11986. [PMID: 31427745 DOI: 10.1038/s41598-019-48502-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
27 Randon M, Lévy-Gabriel C, Abbas R, Dendale R, Lumbroso L, Desjardins L, Cassoux N. Results of external beam radiotherapy for diffuse choroidal hemangiomas in Sturge-Weber syndrome. Eye (Lond) 2018;32:1067-73. [PMID: 29403070 DOI: 10.1038/s41433-018-0024-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
28 El-Essawy R, Galal R, Abdelbaki S. Nonselective β-blocker propranolol for orbital and periorbital hemangiomas in infants: a new first-line of treatment? Clin Ophthalmol 2011;5:1639-44. [PMID: 22140311 DOI: 10.2147/OPTH.S24141] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
29 Pandey V, Tiwari P, Gangopadhyay AN, Gupta DK, Sharma SP, Kumar V. Propranolol for infantile haemangiomas: experience from a tertiary center. J Cutan Aesthet Surg 2014;7:37-41. [PMID: 24761098 DOI: 10.4103/0974-2077.129975] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
30 Yang H, Hu DL, Shu Q, Guo XD. Efficacy and adverse effects of oral propranolol in infantile hemangioma: a meta-analysis of comparative studies. World J Pediatr. 2019;15:546-558. [PMID: 31342465 DOI: 10.1007/s12519-019-00285-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
31 Kelchen MN, Brogden NK. Effect of dosing regimen and microneedle pretreatment on in vitro skin retention of topically applied beta-blockers. Biomed Microdevices 2018;20:100. [PMID: 30523423 DOI: 10.1007/s10544-018-0348-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Furuta S, Sato H, Tsuji S, Murakami F, Kitagawa H. Effective treatment for infantile hemangioma with long-pulsed dye laser with oral propranolol medication: a preliminary report. Pediatr Surg Int 2016;32:857-62. [PMID: 27461431 DOI: 10.1007/s00383-016-3942-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
33 Shikata D, Nakagomi T, Yokoyama Y, Yamada Y, Nakajima M, Oyama T, Goto T. Debulking surgery for venous hemangioma arising from the epicardium: report of a case. World J Surg Oncol 2017;15:81. [PMID: 28403869 DOI: 10.1186/s12957-017-1152-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
34 Calvani M, Subbiani A, Bruno G, Favre C. Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression. Oxid Med Cell Longev 2020;2020:7534693. [PMID: 32855766 DOI: 10.1155/2020/7534693] [Reference Citation Analysis]
35 Zheng N, Ding X, Jahan R. Low concentration of rapamycin inhibits hemangioma endothelial cell proliferation, migration, and vascular tumor formation in mice. Curr Ther Res Clin Exp. 2014;11:99-103. [PMID: 25408787 DOI: 10.1016/j.curtheres.2014.09.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
36 Liang N, Zhang C, Dill P, Panasyuk G, Pion D, Koka V, Gallazzini M, Olson EN, Lam H, Henske EP, Dong Z, Apte U, Pallet N, Johnson RL, Terzi F, Kwiatkowski DJ, Scoazec JY, Martignoni G, Pende M. Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. J Exp Med. 2014;211:2249-2263. [PMID: 25288394 DOI: 10.1084/jem.20140341] [Cited by in Crossref: 112] [Cited by in F6Publishing: 109] [Article Influence: 14.0] [Reference Citation Analysis]
37 Ambika H, Sujatha C, Kumar YH. Topical timolol: a safer alternative for complicated and un-complicated infantile hemangiomas. Indian J Dermatol 2013;58:330. [PMID: 23919041 DOI: 10.4103/0019-5154.113997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
38 Dornhoffer JR, Wei T, Zhang H, Miller E, A Cleves M, Richter GT. The expression of renin-angiotensin-aldosterone axis components in infantile hemangioma tissue and the impact of propranolol treatment. Pediatr Res 2017;82:155-63. [PMID: 28376078 DOI: 10.1038/pr.2017.93] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
39 Zhou C, Chen X, Zeng W, Peng C, Huang G, Li X, Ouyang Z, Luo Y, Xu X, Xu B, Wang W, He R, Zhang X, Zhang L, Liu J, Knepper TC, He Y, McLeod HL. Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway. Oncotarget 2016;7:68314-27. [PMID: 27582542 DOI: 10.18632/oncotarget.11599] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
40 Wagner MJ, Cranmer LD, Loggers ET, Pollack SM. Propranolol for the treatment of vascular sarcomas. J Exp Pharmacol 2018;10:51-8. [PMID: 30233257 DOI: 10.2147/JEP.S146211] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
41 Li X, Yang K, Li H, Huo R. Propranolol Treatment for Infantile Hemangiomas: Short-Term Adverse Effects and Follow-Up to Age Two. Biomed Res Int 2019;2019:2728952. [PMID: 31886190 DOI: 10.1155/2019/2728952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Men CJ, Ediriwickrema LS, Paik JS, Murdock J, Yen MT, Ng JD, Liu CY, Korn BS, Kikkawa DO. Surgical Intervention of Periocular Infantile Hemangiomas in the Era of β-Blockers. Ophthalmic Plast Reconstr Surg 2020;36:70-3. [PMID: 31809485 DOI: 10.1097/IOP.0000000000001466] [Reference Citation Analysis]
43 Grzesik P, Wu JK. Current perspectives on the optimal management of infantile hemangioma. Pediatric Health Med Ther 2017;8:107-16. [PMID: 29388636 DOI: 10.2147/PHMT.S115528] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
44 Czechowicz JA, Benjamin T, Bly RA, Ganti SN, Balkin DM, Perkins JA, Frieden IJ, Rosbe KW. Airway Hemangiomas in PHACE Syndrome: A Multicenter Experience. Otolaryngol Head Neck Surg 2021;165:182-6. [PMID: 33076780 DOI: 10.1177/0194599820966622] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Droho S, Cuda CM, Perlman H, Lavine JA. Monocyte-Derived Macrophages Are Necessary for Beta-Adrenergic Receptor-Driven Choroidal Neovascularization Inhibition. Invest Ophthalmol Vis Sci 2019;60:5059-69. [PMID: 31800964 DOI: 10.1167/iovs.19-28165] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
46 Yao TH, Pataer P, Regmi KP, Gu XW, Li QY, Du JT, Ge SM, Tu JB. Propranolol induces hemangioma endothelial cell apoptosis via a p53BAX mediated pathway. Mol Med Rep. 2018;18:684-694. [PMID: 29767244 DOI: 10.3892/mmr.2018.9013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
47 Zhang L, Yuan WE, Zheng JW. Pharmacological therapies for infantile hemangiomas: A clinical study in 853 consecutive patients using a standard treatment algorithm. Sci Rep 2016;6:21670. [PMID: 26876800 DOI: 10.1038/srep21670] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
48 Bota M, Fischer-Fodor E, Bochiș OV, Cenariu M, Popa G, Blag CL, Tătaru A. Combined effect of propranolol, vincristine and bevacizumab on HUVECs and BJ cells. Exp Ther Med 2019;17:307-15. [PMID: 30651796 DOI: 10.3892/etm.2018.6925] [Reference Citation Analysis]
49 Hassan BA, Shreef KS. Propranolol in treatment of huge and complicated infantile hemangiomas in egyptian children. Dermatol Res Pract 2014;2014:541810. [PMID: 24899888 DOI: 10.1155/2014/541810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Ovadia SA. Discussion on Vascular Malformations: Current Progress Toward Drug Therapy. J Craniofac Surg 2021;32:1215. [PMID: 33306651 DOI: 10.1097/SCS.0000000000007336] [Reference Citation Analysis]
51 Fette A. Propranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapy. ScientificWorldJournal 2013;2013:850193. [PMID: 23766715 DOI: 10.1155/2013/850193] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
52 Pandey A, Singh A, Ali W, Srivastava A, Gupta A, Kureel SN, Rawat J, Wakhlu A. Evaluation of Effect of Propranolol on Serum Vascular Endothelial Growth Factor and Tissue Inhibitor of Metalloproteinase-2 Levels in Infantile Hemangioma. J Indian Assoc Pediatr Surg 2020;25:96-102. [PMID: 32139988 DOI: 10.4103/jiaps.JIAPS_22_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
53 Garcia-Doval I, Ingram JR, Naldi L, Anstey A. Case reports in dermatology: loved by clinicians, loathed by editors, and occasionally important. Br J Dermatol 2016;175:449-51. [PMID: 27632956 DOI: 10.1111/bjd.14869] [Cited by in Crossref: 11] [Article Influence: 1.8] [Reference Citation Analysis]
54 Engineer DR, Burney BO, Hayes TG, Garcia JM. Exposure to ACEI/ARB and β-Blockers Is Associated with Improved Survival and Decreased Tumor Progression and Hospitalizations in Patients with Advanced Colon Cancer. Transl Oncol. 2013;6:539-545. [PMID: 24151534 DOI: 10.1593/tlo.13346] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
55 Zvizdic D, Bulja D, Sidran A, Skenderi F, Zvizdic Z, Vranic S. Isolated deep orbital hemangioma treated successfully with oral propranolol in a 2-month-old infant: Case report with literature review. Am J Ophthalmol Case Rep 2021;22:101095. [PMID: 33981915 DOI: 10.1016/j.ajoc.2021.101095] [Reference Citation Analysis]
56 Bertino F, Trofimova AV, Gilyard SN, Hawkins CM. Vascular anomalies of the head and neck: diagnosis and treatment. Pediatr Radiol 2021;51:1162-84. [PMID: 33860862 DOI: 10.1007/s00247-021-04968-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Wang C, Wang Y, Sun Y. Treatment of infantile subglottic hemangioma with oral propranolol: Infantile subglottic hemangioma. Pediatrics International 2016;58:385-8. [DOI: 10.1111/ped.12813] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
58 Campbell V, Beckett R, Abid N, Hoey S. Resolution of Consumptive Hypothyroidism Secondary to Infantile Hepatic Hemangiomatosis with a Combination of Propranolol and Levothyroxine. J Clin Res Pediatr Endocrinol 2018;10:294-8. [PMID: 29537380 DOI: 10.4274/jcrpe.4865] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
59 Wang F, Wang FM, Lv HM, Han T. Role of β2 adrenergic receptor signaling pathway in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2016; 24(24): 3598-3606 [DOI: 10.11569/wcjd.v24.i24.3598] [Reference Citation Analysis]
60 Sand M, Sand D, Thrandorf C, Paech V, Altmeyer P, Bechara FG. Cutaneous lesions of the nose. Head Face Med 2010;6:7. [PMID: 20525327 DOI: 10.1186/1746-160X-6-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
61 Srinivasan AV. Propranolol: A 50-Year Historical Perspective. Ann Indian Acad Neurol 2019;22:21-6. [PMID: 30692755 DOI: 10.4103/aian.AIAN_201_18] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
62 Lavine JA, Farnoodian M, Wang S, Darjatmoko SR, Wright LS, Gamm DM, Ip MS, Sorenson CM, Sheibani N. β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression. Invest Ophthalmol Vis Sci 2017;58:299-308. [PMID: 28114591 DOI: 10.1167/iovs.16-20204] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
63 Jaiswal H, Patidar N, Shah C, Singh R, Jain E, Piyush P. Topical timolol 0.5% as the primary treatment of ophthalmic pyogenic granuloma: A prospective, single-arm study. Indian J Ophthalmol 2021;69:1155-60. [PMID: 33913850 DOI: 10.4103/ijo.IJO_2404_20] [Reference Citation Analysis]
64 Bassi A, Filippeschi C, Oranges T, Caporalini C, Pini A, Nardini P, Gentile RM, Filippi L. Infantile hemangiomas β3-adrenoceptor overexpression is associated with nonresponse to propranolol. Pediatr Res 2021. [PMID: 33654276 DOI: 10.1038/s41390-021-01385-x] [Reference Citation Analysis]
65 Zalimas A, Posiunas G, Strupas S, Raugalas R, Raistenskis J, Verkauskas G. Cloacal reconstruction after a complex treatment of perineal haemangioma in a variant of PELVIS syndrome. BMC Pediatr 2015;15:150. [PMID: 26450698 DOI: 10.1186/s12887-015-0469-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
66 He J, Zhang Z, Zheng X, Li L, Qi J, Wu W, Lu Y. Design and Evaluation of Dissolving Microneedles for Enhanced Dermal Delivery of Propranolol Hydrochloride. Pharmaceutics 2021;13:579. [PMID: 33921712 DOI: 10.3390/pharmaceutics13040579] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Huang AH, Mannschreck D, Aggarwal P, Mahon M, Cohen BA. Retrospective case series of increased oral propranolol dosage for infantile hemangiomas. Pediatr Dermatol 2020;37:1057-62. [PMID: 32869385 DOI: 10.1111/pde.14281] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Pasquier E, Ciccolini J, Carre M, Giacometti S, Fanciullino R, Pouchy C, Montero MP, Serdjebi C, Kavallaris M, André N. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment. Oncotarget 2011;2:797-809. [PMID: 22006582 DOI: 10.18632/oncotarget.343] [Cited by in Crossref: 131] [Cited by in F6Publishing: 133] [Article Influence: 13.1] [Reference Citation Analysis]
69 Mei-Zahav M, Gendler Y, Bruckheimer E, Prais D, Birk E, Watad M, Goldschmidt N, Soudry E. Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial. J Clin Med 2020;9:E3130. [PMID: 32998220 DOI: 10.3390/jcm9103130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Raabe EH, Keefer JR, Mitchell SE, Hong K, DiFazio M, Strouse JJ. Subtotal splenic embolization is a safe and effective treatment for isolated splenic vascular tumors associated with consumptive coagulopathy. J Pediatr Hematol Oncol 2011;33:383-6. [PMID: 21606851 DOI: 10.1097/MPH.0b013e3182172515] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
71 Biswas A, Pan X, Meyer M, Khanna S, Roy S, Pearson G, Kirschner R, Witman P, Faith EF, Sen CK, Gordillo GM. Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation. Plast Reconstr Surg 2017;139:1277e-84e. [PMID: 28538565 DOI: 10.1097/PRS.0000000000003349] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
72 Yamamoto H, Beppu S. Left ventricular cardiac hemangioma in a patient with chronic heart failure. J Med Ultrason (2001) 2018;45:509-13. [PMID: 29280024 DOI: 10.1007/s10396-017-0852-z] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
73 Chiu YE, Drolet BA, Blei F, Carcao M, Fangusaro J, Kelly ME, Krol A, Lofgren S, Mancini AJ, Metry DW, Recht M, Silverman RA, Tom WL, Pope E. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Pediatr Blood Cancer 2012;59:934-8. [PMID: 22648868 DOI: 10.1002/pbc.24103] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 7.7] [Reference Citation Analysis]
74 El-Raggal NM, El-Farrash RA, Saad AA, Attia EAS, Saafan HA, Shaaban IS. Circulating Levels of Vascular Endothelial Growth Factor and Basic Fibroblastic Growth Factor in Infantile Hemangioma Versus Vascular Malformations. Clin Appl Thromb Hemost 2018;24:663-8. [PMID: 28595487 DOI: 10.1177/1076029617710333] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
75 Duan P, Huang Y, Chen K, Cheng C, Wu Z, Wu Y. 15,16-dihydrotanshinone I inhibits EOMA cells proliferation by interfering in posttranscriptional processing of hypoxia-inducible factor 1. Int J Med Sci 2021;18:3214-23. [PMID: 34400891 DOI: 10.7150/ijms.60774] [Reference Citation Analysis]
76 Tiwari P, Mahajan V, Muhrerkar K, Sunil BJ, Ramakrishnan A, Ganesan T. Effectiveness of Sorafenib in Hepatic Hemangioma. J Glob Oncol 2018;4:1-4. [PMID: 30241175 DOI: 10.1200/JGO.2016.008573] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Moyakine AV, Vleuten CJVD. Propranolol for infantile hemangioma: Current state of affairs. World J Dermatol 2016; 5(1): 4-16 [DOI: 10.5314/wjd.v5.i1.4] [Reference Citation Analysis]
78 Kilmister EJ, Hansen L, Davis PF, Hall SRR, Tan ST. Cell Populations Expressing Stemness-Associated Markers in Vascular Anomalies. Front Surg 2020;7:610758. [PMID: 33634164 DOI: 10.3389/fsurg.2020.610758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
79 Mantelli F, Bruscolini A, La Cava M, Abdolrahimzadeh S, Lambiase A. Ocular manifestations of Sturge-Weber syndrome: pathogenesis, diagnosis, and management. Clin Ophthalmol 2016;10:871-8. [PMID: 27257371 DOI: 10.2147/OPTH.S101963] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
80 Bota M, Popa G, Blag CL, Leucuta DC, Tătaru A. Infantile hemangiomas: a 7-year experience of a single-center. Clujul Med 2017;90:396-400. [PMID: 29151787 DOI: 10.15386/cjmed-781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
81 Uzunaslan D, Saygin C, Gungor S, Hasiloglu Z, Ozdemir N, Celkan T. Novel use of propranolol for management of pain in children with vertebral hemangioma: report of two cases. Childs Nerv Syst 2013;29:855-60. [PMID: 23306960 DOI: 10.1007/s00381-012-2012-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
82 Su WT, Xue JX, Ke YH. Noteworthy effects of a long-pulse Alexandrite laser for treatment of high-risk infantile hemangioma: A case report and literature review. World J Clin Cases 2019; 7(14): 1876-1883 [PMID: 31417934 DOI: 10.12998/wjcc.v7.i14.1876] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
83 Kim JA, Choi YB, Yi ES, Lee JW, Sung KW, Koo HH, Yoo KH. Excellent outcome of medical treatment for Kasabach-Merritt syndrome: a single-center experience. Blood Res 2016;51:256-60. [PMID: 28090488 DOI: 10.5045/br.2016.51.4.256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
84 Nissen T, Wynn R. The clinical case report: a review of its merits and limitations. BMC Res Notes. 2014;7:264. [PMID: 24758689 DOI: 10.1186/1756-0500-7-264] [Cited by in Crossref: 168] [Cited by in F6Publishing: 129] [Article Influence: 21.0] [Reference Citation Analysis]
85 Burne R, Taylor R; Medscape. Monitoring propranolol treatment in periocular infantile haemangioma. Eye (Lond) 2014;28:1281-4; quiz 1285. [PMID: 25323853 DOI: 10.1038/eye.2014.237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
86 Khorsand K, Sidbury R. Recent advances in paediatric dermatology. Archives of Disease in Childhood 2014;99:944-8. [DOI: 10.1136/archdischild-2013-304398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 Chen J, Joyal JS, Hatton CJ, Juan AM, Pei DT, Hurst CG, Xu D, Stahl A, Hellstrom A, Smith LE. Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2012;53:2968-2977. [PMID: 22491401 DOI: 10.1167/iovs.12-9691] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
88 Levy ML. Propranolol for infantile hemangiomas. Glob Adv Health Med 2012;1:14-6. [PMID: 24278812 DOI: 10.7453/gahmj.2012.1.2.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
89 Filippi L, Cammalleri M, Amato R, Ciantelli M, Pini A, Bagnoli P, Dal Monte M. Decoupling Oxygen Tension From Retinal Vascularization as a New Perspective for Management of Retinopathy of Prematurity. New Opportunities From β-adrenoceptors. Front Pharmacol 2022;13:835771. [DOI: 10.3389/fphar.2022.835771] [Reference Citation Analysis]
90 Ishida J, Konishi M, Ebner N, Springer J. Repurposing of approved cardiovascular drugs. J Transl Med 2016;14:269. [PMID: 27646033 DOI: 10.1186/s12967-016-1031-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
91 Hon KL, Burd A, Chu WC, Lee V, Li CK. Propranolol for infantile hemangiomas: strawberry matters? Indian J Pediatr 2012;79:130-1. [PMID: 21779825 DOI: 10.1007/s12098-011-0527-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
92 Hamm H, Höger PH. Skin tumors in childhood. Dtsch Arztebl Int 2011;108:347-53. [PMID: 21655460 DOI: 10.3238/arztebl.2011.0347] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
93 Janmohamed SR, Madern GC, Nieuwenhuis K, de Laat PC, Oranje AP. Evaluation of intra-lesional corticosteroids in the treatment of peri-ocular haemangioma of infancy: still an alternative besides propranolol. Pediatr Surg Int 2012;28:393-8. [PMID: 22200732 DOI: 10.1007/s00383-011-3037-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
94 Bertoni N, Pereira LM, Severino FE, Moura R, Yoshida WB, Reis PP. Integrative meta-analysis identifies microRNA-regulated networks in infantile hemangioma. BMC Med Genet 2016;17:4. [PMID: 26772808 DOI: 10.1186/s12881-015-0262-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
95 Mehta A, Bajaj MS, Pushker N, Chawla B, Pujari A, Grewal SS, Grewal SPS, Singh SR, Kishore A, Yadav NS. To compare intralesional and oral propranolol for treating periorbital and eyelid capillary hemangiomas. Indian J Ophthalmol 2019;67:1974-80. [PMID: 31755431 DOI: 10.4103/ijo.IJO_59_19] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
96 Baud J, Lomri A, Graber D, Bikfalvi A. The therapeutic response in Gorham's syndrome to the beta-blocking agent propranolol is correlated to VEGF-A, but not to VEGF-C or FLT1 expression. BMC Res Notes 2015;8:333. [PMID: 26238450 DOI: 10.1186/s13104-015-1259-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
97 Chantasart D, Hao J, Li SK. Evaluation of skin permeation of β-blockers for topical drug delivery. Pharm Res 2013;30:866-77. [PMID: 23208385 DOI: 10.1007/s11095-012-0928-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
98 Ji Y, Chen S, Li K, Xiao X, Zheng S, Xu T. The role of β-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cells. Cell Div 2013;8:1. [PMID: 23286511 DOI: 10.1186/1747-1028-8-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 7.0] [Reference Citation Analysis]
99 Gomez-Acevedo H, Dai Y, Strub G, Shawber C, Wu JK, Richter GT. Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration. Sci Rep 2020;10:3261. [PMID: 32094357 DOI: 10.1038/s41598-020-60025-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
100 Sebaratnam DF, Rodríguez Bandera AL, Wong LF, Wargon O. Infantile hemangioma. Part 2: Management. J Am Acad Dermatol 2021;85:1395-404. [PMID: 34419523 DOI: 10.1016/j.jaad.2021.08.020] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
101 England RW, Hardy KL, Kitajewski AM, Wong A, Kitajewski JK, Shawber CJ, Wu JK. Propranolol promotes accelerated and dysregulated adipogenesis in hemangioma stem cells. Ann Plast Surg 2014;73 Suppl 1:S119-24. [PMID: 25115372 DOI: 10.1097/SAP.0000000000000272] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
102 Deshmukh A, Pant S, Bhatt P, Mehta JL. Association of Hypertension and Anti-Hypertensive Therapy with Cancers. Curr Cardiovasc Risk Rep 2012;6:261-6. [DOI: 10.1007/s12170-012-0250-4] [Reference Citation Analysis]
103 Qu H, Lei X, Hu L, Yin X, Du X, Zhang L, Sun C. Successful Endoscopic Sclerotherapy Using Lauromacrogol Injection for Laryngopharyngeal Hemangioma. Ear Nose Throat J 2021;100:662-6. [PMID: 34551625 DOI: 10.1177/01455613211043690] [Reference Citation Analysis]
104 Löser C, Möhrle M. [Special aspects of dermatologic surgery in children]. Hautarzt 2012;63:121-8. [PMID: 22307411 DOI: 10.1007/s00105-011-2200-3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
105 Wu HW, Wang X, Zhang L, Zheng JW, Liu C, Wang YA. Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas. Front Oncol 2018;8:605. [PMID: 30619747 DOI: 10.3389/fonc.2018.00605] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
106 Filippi L, Pini A, Cammalleri M, Bagnoli P, Dal Monte M. β3-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: Suggestive clues from embryo. Med Res Rev 2021. [PMID: 34967048 DOI: 10.1002/med.21874] [Reference Citation Analysis]
107 Rokugo Y, Ota C, Kimura M, Sasahara Y. Preoperative administration of propranolol reduced the surgical risks of PHACES syndrome in a 14-month-old girl. BMJ Case Rep 2019;12:e228117. [PMID: 31036736 DOI: 10.1136/bcr-2018-228117] [Reference Citation Analysis]
108 Bjelakovic B, Bojanovic M, Lukic S, Saranac L, Vukomanovic V, Prijic S, Zivkovic N, Randjelovic D. The therapeutic efficacy of propranolol in children with recurrent primary epistaxis. Drug Des Devel Ther 2013;7:127-9. [PMID: 23467483 DOI: 10.2147/DDDT.S41756] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
109 Richter GT, Friedman AB. Hemangiomas and vascular malformations: current theory and management. Int J Pediatr 2012;2012:645678. [PMID: 22611412 DOI: 10.1155/2012/645678] [Cited by in Crossref: 120] [Cited by in F6Publishing: 87] [Article Influence: 12.0] [Reference Citation Analysis]
110 Yoon DJ, Kaur R, Gallegos A, West K, Yang H, Schaefer S, Tchanque-Fossuo C, Dahle SE, Isseroff RR. Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events. Am J Clin Dermatol 2021;22:89-99. [PMID: 33237496 DOI: 10.1007/s40257-020-00567-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Arneja JS. Where have we arrived in the care of vascular anomalies a generation after Mulliken's classification system? Can J Plast Surg 2012;20:65. [PMID: 23730151 DOI: 10.1177/229255031202000214] [Reference Citation Analysis]
112 Sharma VK, Fraulin FO, Dumestre DO, Walker L, Harrop AR. Beta-blockers for the treatment of problematic hemangiomas. Can J Plast Surg 2013;21:23-8. [PMID: 24431932 DOI: 10.1177/229255031302100103] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
113 Snir M, Reich U, Siegel R, Zvulunov A, Friling R, Goldenberg-Cohen N, Ron Y, Ben-Amitay D. Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol. Eye (Lond) 2011;25:1627-34. [PMID: 21921959 DOI: 10.1038/eye.2011.233] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
114 Espahbodi M, Yan K, Chun RH, McCormick ME. Management trends of infantile hemangioma: A national perspective. Int J Pediatr Otorhinolaryngol 2018;104:84-7. [PMID: 29287888 DOI: 10.1016/j.ijporl.2017.10.044] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
115 Lubahn JG, Lee RK, Karp CL. Resolution of conjunctival sessile hemangioma with topical timolol. Cornea 2014;33:99-100. [PMID: 24270678 DOI: 10.1097/ICO.0000000000000022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
116 Chu DH, Castelo-Soccio L, Wan J, Gelfand JM, Shaddy RE, Shah KN, Perman MJ, Treat JR, Yan AC. Retrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study). Clin Pediatr (Phila) 2014;53:1084-90. [PMID: 24849505 DOI: 10.1177/0009922814535660] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
117 Sartages M, Floridia E, García-Colomer M, Iglesias C, Macía M, Peñas P, Couraud PO, Romero IA, Weksler B, Pombo CM, Zalvide J. High Levels of Receptor Tyrosine Kinases in CCM3-Deficient Cells Increase Their Susceptibility to Tyrosine Kinase Inhibition. Biomedicines 2020;8:E624. [PMID: 33348877 DOI: 10.3390/biomedicines8120624] [Reference Citation Analysis]
118 Liu Z, Lv S, Wang S, Qu SM, Zhang GY, Lin YT, Yang L, Li FQ. Itraconazole therapy for infant hemangioma: Two case reports. World J Clin Cases 2021; 9(28): 8579-8586 [PMID: 34754871 DOI: 10.12998/wjcc.v9.i28.8579] [Reference Citation Analysis]
119 Brennan TE, Waner M, O TM. The Tissue Expander Effect in Early Surgical Management of Select Focal Infantile Hemangiomas. JAMA Facial Plast Surg 2017;19:282-6. [PMID: 28152134 DOI: 10.1001/jamafacial.2016.1991] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
120 Avgitidou G, Koch KR, Cursiefen C, Heindl LM. [Current aspects of eyelid, lacrimal and orbital surgery in childhood]. Ophthalmologe 2015;112:102-9. [PMID: 25636583 DOI: 10.1007/s00347-014-3054-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
121 Gnarra M, Behr G, Kitajewski A, Wu JK, Anupindi SA, Shawber CJ, Zavras N, Schizas D, Salakos C, Economopoulos KP. History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis. World J Clin Pediatr 2016; 5(3): 273-280 [PMID: 27610342 DOI: 10.5409/wjcp.v5.i3.273] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
122 Mimura H, Akita S, Fujino A, Jinnin M, Ozaki M, Osuga K, Nakaoka H, Morii E, Kuramochi A, Aoki Y, Arai Y, Aramaki N, Inoue M, Iwashina Y, Iwanaka T, Ueno S, Umezawa A, Ozeki M, Ochi J, Kinoshita Y, Kurita M, Seike S, Takakura N, Takahashi M, Tachibana T, Chuman K, Nagata S, Narushima M, Niimi Y, Nosaka S, Nozaki T, Hashimoto K, Hayashi A, Hirakawa S, Fujikawa A, Hori Y, Matsuoka K, Mori H, Yamamoto Y, Yuzuriha S, Rikihisa N, Watanabe S, Watanabe S, Kuroda T, Sugawara S, Ishikawa K, Sasaki S. Japanese Clinical Practice Guidelines for Vascular Anomalies 2017. J Dermatol 2020;47:e138-83. [PMID: 32200557 DOI: 10.1111/1346-8138.15189] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Melo JN, Rotter A, Rivitti-Machado MC, Oliveira ZN. Propranolol for treatment of infantile hemangiomas. An Bras Dermatol 2013;88:220-3. [PMID: 24346925 DOI: 10.1590/abd1806-4841.20131699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
124 Cheng J, Virbalas J. Vascular Anomalies in Otolaryngology-Head and Neck Surgery Resident Education. Otolaryngol Head Neck Surg 2014;151:187-9. [PMID: 24812080 DOI: 10.1177/0194599814534594] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
125 Al-Rwebah H, Alkhodair R, Al-Khenaizan S. Propranolol-induced hyperkalemia in the management of infantile hemangioma. JAAD Case Rep 2020;6:359-61. [PMID: 32258322 DOI: 10.1016/j.jdcr.2020.01.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Chen M, Singh AK, Repasky EA. Highlighting the Potential for Chronic Stress to Minimize Therapeutic Responses to Radiotherapy through Increased Immunosuppression and Radiation Resistance. Cancers (Basel) 2020;12:E3853. [PMID: 33419318 DOI: 10.3390/cancers12123853] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Mong EF, Akat KM, Canfield J, Lockhart J, VanWye J, Matar A, Tsibris JCM, Wu JK, Tuschl T, Totary-Jain H. Modulation of LIN28B/Let-7 Signaling by Propranolol Contributes to Infantile Hemangioma Involution. Arterioscler Thromb Vasc Biol 2018;38:1321-32. [PMID: 29724816 DOI: 10.1161/ATVBAHA.118.310908] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
128 Pope E, Lara-Corrales I, Sibbald C, Liy-Wong C, Kanigsberg N, Drolet B, Ma J. Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial. JAMA Pediatr 2021. [PMID: 34747977 DOI: 10.1001/jamapediatrics.2021.4565] [Reference Citation Analysis]
129 Ishida Y, Otsuka A, Kabashima K. Cutaneous angiosarcoma: update on biology and latest treatment. Curr Opin Oncol 2018;30:107-12. [PMID: 29194075 DOI: 10.1097/CCO.0000000000000427] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
130 Stiles J, Amaya C, Pham R, Rowntree RK, Lacaze M, Mulne A, Bischoff J, Kokta V, Boucheron LE, Mitchell DC, Bryan BA. Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis. Exp Ther Med 2012;4:594-604. [PMID: 23170111 DOI: 10.3892/etm.2012.654] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
131 Dickerson EB, Bryan BA. Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma. Vet Sci 2015;2:270-92. [PMID: 29061946 DOI: 10.3390/vetsci2030270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
132 Sipkova Z, Xue K, Mudhar HS, Wagner B, Hildebrand GD. Early and Late Histological and Ultrastructural Findings in Resected Infantile Capillary Hemangiomas Following Treatment with Topical Beta-Blocker Timolol Maleate 0.5. Ocul Oncol Pathol 2018;4:100-6. [PMID: 30320089 DOI: 10.1159/000477411] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
133 Zhang T, Qian Y, Yuan C, Wu Y, Qian H, Lu H, Hu C, Li W. Propranolol Suppresses Proliferation and Migration of HUVECs through Regulation of the miR-206/VEGFA Axis. Biomed Res Int 2021;2021:7629176. [PMID: 34697590 DOI: 10.1155/2021/7629176] [Reference Citation Analysis]
134 Engberg Damsgaard T, Vandborg Bjerre J. Haemangioma and propranolol. J Plast Surg Hand Surg 2014;48:86-8. [PMID: 23837510 DOI: 10.3109/2000656X.2012.754622] [Reference Citation Analysis]
135 Tapping CR, Bratby MJ. The changing face of vascular interventional radiology: the future role of pharmacotherapies and molecular imaging. Cardiovasc Intervent Radiol 2013;36:904-12. [PMID: 23636247 DOI: 10.1007/s00270-013-0621-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
136 Taylor RH. Infantile Periocular Haemangioma: Optimising the Therapeutic Response. Paediatr Drugs 2016;18:157-60. [PMID: 27043724 DOI: 10.1007/s40272-016-0172-6] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
137 Kum JJ, Khan ZA. Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis. Pediatr Res 2014;75:381-8. [PMID: 24296797 DOI: 10.1038/pr.2013.231] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
138 Roda N, Blandano G, Pelicci PG. Blood Vessels and Peripheral Nerves as Key Players in Cancer Progression and Therapy Resistance. Cancers (Basel) 2021;13:4471. [PMID: 34503281 DOI: 10.3390/cancers13174471] [Reference Citation Analysis]
139 Sakata N, Suenobu SI, Okano M, Ueda S, Kimura M, Takemura T. Impact of sirolimus treatment for refractory kaposiform hemangioendothelioma with exacerbation of the disease 10 years after initial diagnosis. Rare Tumors 2018;10:2036361318776185. [PMID: 29872523 DOI: 10.1177/2036361318776185] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
140 Arima M, Fujii Y, Sonoda KH. Translational Research in Retinopathy of Prematurity: From Bedside to Bench and Back Again. J Clin Med 2021;10:331. [PMID: 33477419 DOI: 10.3390/jcm10020331] [Reference Citation Analysis]
141 Greenberger S, Bischoff J. Infantile hemangioma-mechanism(s) of drug action on a vascular tumor. Cold Spring Harb Perspect Med 2011;1:a006460. [PMID: 22229118 DOI: 10.1101/cshperspect.a006460] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
142 Ou HC, Santos F, Raible DW, Simon JA, Rubel EW. Drug screening for hearing loss: using the zebrafish lateral line to screen for drugs that prevent and cause hearing loss. Drug Discov Today 2010;15:265-71. [PMID: 20096805 DOI: 10.1016/j.drudis.2010.01.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
143 Borst AJ, Nakano TA, Blei F, Adams DM, Duis J. A Primer on a Comprehensive Genetic Approach to Vascular Anomalies. Front Pediatr 2020;8:579591. [PMID: 33194911 DOI: 10.3389/fped.2020.579591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
144 Stiles JM, Amaya C, Rains S, Diaz D, Pham R, Battiste J, Modiano JF, Kokta V, Boucheron LE, Mitchell DC, Bryan BA. Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma. PLoS One. 2013;8:e60021. [PMID: 23555867 DOI: 10.1371/journal.pone.0060021] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 6.2] [Reference Citation Analysis]
145 Eivazi B, Wiegand S, Teymoortash A, Neff A, Werner JA. Laser treatment of mucosal venous malformations of the upper aerodigestive tract in 50 patients. Lasers Med Sci 2010;25:571-6. [PMID: 20217166 DOI: 10.1007/s10103-010-0762-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
146 Blanke K, Dähnert I, Salameh A. Role of connexins in infantile hemangiomas. Front Pharmacol 2013;4:41. [PMID: 23596415 DOI: 10.3389/fphar.2013.00041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
147 Greenberger S, Yuan S, Walsh LA, Boscolo E, Kang KT, Matthews B, Mulliken JB, Bischoff J. Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma. J Invest Dermatol. 2011;131:2467-2476. [PMID: 21938011 DOI: 10.1038/jid.2011.300] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
148 Roth IM, Wickremesekera AC, Wickremesekera SK, Davis PF, Tan ST. Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System. Front Oncol 2019;9:745. [PMID: 31440473 DOI: 10.3389/fonc.2019.00745] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
149 Galván DC, Ayyappan AP, Bryan BA. Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment. Oncoscience 2018;5:264-8. [PMID: 30460329 DOI: 10.18632/oncoscience.472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
150 Yuzuriha S, Nagai F, Noguchi M. How to Manage Disfiguring Scars in Involuted Infantile Hemangioma. Adv Wound Care (New Rochelle) 2019;8:221-9. [PMID: 31737416 DOI: 10.1089/wound.2018.0847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
151 He L, Huang G. Spectral Doppler ultrasound for predicting long-term response to topical timolol in children with infantile hemangioma: Predicting timolol response in hemangioma. J Clin Ultrasound 2017;45:480-7. [DOI: 10.1002/jcu.22471] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
152 Gałązka P, Bereźnicka W, Leis K, Kaczor P, Daniluk-Matraś I, Czajkowski R, Bolewicz-Planutis I. Treatment of haemangiomas using propranolol in paediatric patients: a retrospective cohort study. Postepy Dermatol Alergol 2020;37:603-7. [PMID: 32994786 DOI: 10.5114/ada.2020.98282] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
153 Coondoo A, Sengupta S. Serendipity and its role in dermatology. Indian J Dermatol 2015;60:130-5. [PMID: 25814699 DOI: 10.4103/0019-5154.152504] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
154 Anderson KR, Schoch JJ, Lohse CM, Hand JL, Davis DM, Tollefson MM. Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight. J Am Acad Dermatol 2016;74:120-6. [PMID: 26494585 DOI: 10.1016/j.jaad.2015.08.024] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
155 Li L, Yang B, Wei L, Zhang B, Han XF, Xu ZG, Ma L. Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies. BMC Pediatr 2020;20:78. [PMID: 32075603 DOI: 10.1186/s12887-020-1974-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
156 Yee-Hang WB, Theresa H, So-Lun L, Wai-Kuen H, Ignace WW. Stridor in asian infants: assessment and treatment. ISRN Otolaryngol 2012;2012:915910. [PMID: 23724274 DOI: 10.5402/2012/915910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
157 Pantziarka P, Hutchinson L, André N, Benzekry S, Bertolini F, Bhattacharjee A, Chiplunkar S, Duda DG, Gota V, Gupta S, Joshi A, Kannan S, Kerbel R, Kieran M, Palazzo A, Parikh A, Pasquier E, Patil V, Prabhash K, Shaked Y, Sholler GS, Sterba J, Waxman DJ, Banavali S. Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai. Ecancermedicalscience 2016;10:689. [PMID: 27994645 DOI: 10.3332/ecancer.2016.689] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
158 Bejjanki KM, Akhtar K, Gupta AP, Kaliki S. Effect of Oral Propranolol on Periocular Infantile Capillary Hemangioma: Outcomes Based on Extent of Involvement. Middle East Afr J Ophthalmol 2021;28:6-10. [PMID: 34321816 DOI: 10.4103/meajo.MEAJO_228_19] [Reference Citation Analysis]
159 Wong A, Hardy KL, Kitajewski AM, Shawber CJ, Kitajewski JK, Wu JK. Propranolol accelerates adipogenesis in hemangioma stem cells and causes apoptosis of hemangioma endothelial cells. Plast Reconstr Surg 2012;130:1012-21. [PMID: 23096601 DOI: 10.1097/PRS.0b013e318267d3db] [Cited by in Crossref: 66] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
160 Liu C, Zhao ZL, Wu HW, Zheng JW, Wang YA, Liu XJ, Fan XD. Effect of combined low-dose oral prednisone with beta-adrenergic receptor antagonists for refractory infantile hemangiomas: retrospective cohort study in 76 patients. Ann Transl Med 2019;7:750. [PMID: 32042766 DOI: 10.21037/atm.2019.11.94] [Reference Citation Analysis]
161 Pandey A, Singh SP, Verma R, Gupta V. Re: Propranolol for infantile haemangiomas: Early experience from a tertiary center. J Cutan Aesthet Surg 2014;7:137-8. [PMID: 25136223 DOI: 10.4103/0974-2077.138372] [Reference Citation Analysis]
162 Rössler J, Braunschweiger F, Schill T. [Medication-based therapy of infantile hemangioma and lymphatic malformations]. HNO 2014;62:12-8. [PMID: 24434958 DOI: 10.1007/s00106-013-2794-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
163 Fernandez-Pineda I, Cabello-Laureano R. Differential diagnosis and management of liver tumors in infants. World J Hepatol 2014; 6(7): 486-495 [PMID: 25068000 DOI: 10.4254/wjh.v6.i7.486] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
164 Brand C, Pedro MT, Schick M, Scheuerle A, Scheglmann K, Wirtz CR, Antoniadis G. [Intraneural hemangioma of the ulnar nerve]. Nervenarzt 2015;86:197-201. [PMID: 25575631 DOI: 10.1007/s00115-014-4169-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
165 Janmohamed SR, Madern GC, de Laat PC, Oranje AP. Educational paper: Pathogenesis of infantile haemangioma, an update 2014 (part I). Eur J Pediatr 2015;174:97-103. [PMID: 25156689 DOI: 10.1007/s00431-014-2403-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
166 Itani MH, Fakih H. Response of facial haemangioma to oral propranolol. BMJ Case Rep 2009;2009:bcr0120091476. [PMID: 21687034 DOI: 10.1136/bcr.01.2009.1476] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
167 Ocaranza M, Rompel SM, Gutierrez J, Sepulveda W. Forehead hemangioma: a rare location for a large vascular tumor in a fetus. J Ultrasound Med 2011;30:1158-61. [PMID: 21795495 DOI: 10.7863/jum.2011.30.8.1158] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
168 Boscolo E, Bischoff J. Vasculogenesis in infantile hemangioma. Angiogenesis. 2009;12:197-207. [PMID: 19430954 DOI: 10.1007/s10456-009-9148-2] [Cited by in Crossref: 112] [Cited by in F6Publishing: 91] [Article Influence: 8.6] [Reference Citation Analysis]
169 Schiestl C, Neuhaus K, Zoller S, Subotic U, Forster-Kuebler I, Michels R, Balmer C, Weibel L. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr 2011;170:493-501. [PMID: 20936416 DOI: 10.1007/s00431-010-1324-2] [Cited by in Crossref: 84] [Cited by in F6Publishing: 66] [Article Influence: 7.0] [Reference Citation Analysis]
170 Pantziarka P, Bouche G, Sukhatme V, Meheus L, Rooman I, Sukhatme VP. Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent. Ecancermedicalscience 2016;10:680. [PMID: 27899953 DOI: 10.3332/ecancer.2016.680] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
171 Ortonne J. Quoi de neuf en thérapeutique dermatologique ? Annales de Dermatologie et de Vénéréologie 2008;135:S360-70. [DOI: 10.1016/s0151-9638(08)75489-9] [Reference Citation Analysis]
172 Shi W, He H, Jiang J, Gao Y, Quan H. Timing and Efficacy of 595-nm Pulsed-Dye Laser Combined with 0.5% Timolol Maleate Solution in the Treatment of Superficial Infantile Hemangiomas. Clin Cosmet Investig Dermatol 2021;14:1593-9. [PMID: 34754209 DOI: 10.2147/CCID.S337850] [Reference Citation Analysis]
173 Nguyen HP, Pickrell BB, Wright TS. Beta-blockers as therapy for infantile hemangiomas. Semin Plast Surg 2014;28:87-90. [PMID: 25045334 DOI: 10.1055/s-0034-1376259] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
174 Liu C, Zhao Z, Guo S, Zhang L, Fan X, Zheng J. Exosomal miR-27a-3p derived from tumor-associated macrophage suppresses propranolol sensitivity in infantile hemangioma. Cell Immunol 2021;370:104442. [PMID: 34634611 DOI: 10.1016/j.cellimm.2021.104442] [Reference Citation Analysis]
175 Zimbelmann M, Neppert B, Piria R, Babst N, Ponto KA, Grisanti S, Heindl LM, Kakkassery V. [Treatment and management of orbital tumors]. Ophthalmologe 2021;118:1004-11. [PMID: 34406460 DOI: 10.1007/s00347-021-01471-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
176 Kaempfen S, Neumann RP, Jost K, Schulzke SM. Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants. Cochrane Database Syst Rev 2018;3:CD011893. [PMID: 29499081 DOI: 10.1002/14651858.CD011893.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
177 Filippi L, de Libero C, Zamma Gallarati B, Fortunato P, Piozzi E. Propranolol eye drops in patients with corneal neovascularization. Medicine (Baltimore) 2018;97:e13002. [PMID: 30407290 DOI: 10.1097/MD.0000000000013002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
178 Orbay H, Li Y, Xiao W, Cherry SR, Lam K, Sahar DE. Developing a Nanoparticle-Delivered High-Efficacy Treatment for Infantile Hemangiomas Using a Mouse Hemangioendothelioma Model. Plast Reconstr Surg 2016;138:410-7. [PMID: 27465164 DOI: 10.1097/PRS.0000000000002403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
179 Albiñana V, Gallardo-Vara E, de Rojas-P I, Recio-Poveda L, Aguado T, Canto-Cano A, Aguirre DT, Serra MM, González-Peramato P, Martínez-Piñeiro L, Cuesta AM, Botella LM. Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel-Lindau Disease. J Clin Med 2020;9:E2740. [PMID: 32854260 DOI: 10.3390/jcm9092740] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
180 Gomulka J, Siegel DH, Drolet BA. Dramatic shift in the infantile hemangioma treatment paradigm at a single institution. Pediatr Dermatol 2013;30:751-2. [PMID: 24117504 DOI: 10.1111/pde.12229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
181 De Giorgi V, Grazzini M, Benemei S, Marchionni N, Botteri E, Pennacchioli E, Geppetti P, Gandini S. Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study. JAMA Oncol 2018;4:e172908. [PMID: 28973254 DOI: 10.1001/jamaoncol.2017.2908] [Cited by in Crossref: 84] [Cited by in F6Publishing: 74] [Article Influence: 21.0] [Reference Citation Analysis]
182 Lauren C, Garzon MC. Treatment of infantile hemangiomas. Pediatr Ann 2012;41:1-7. [PMID: 22881415 DOI: 10.3928/00904481-20120727-10] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
183 Lavine JA, Sang Y, Wang S, Ip MS, Sheibani N. Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism. JAMA Ophthalmol 2013;131:376-82. [PMID: 23303344 DOI: 10.1001/jamaophthalmol.2013.1476] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
184 Bosemani T, Puttgen KB, Huisman TA, Tekes A. Multifocal infantile hepatic hemangiomas--imaging strategy and response to treatment after propranolol and steroids including review of the literature. Eur J Pediatr. 2012;171:1023-1028. [PMID: 22234480 DOI: 10.1007/s00431-011-1671-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
185 Uebelhoer M, Boon LM, Vikkula M. Vascular anomalies: from genetics toward models for therapeutic trials. Cold Spring Harb Perspect Med 2012;2:a009688. [PMID: 22908197 DOI: 10.1101/cshperspect.a009688] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
186 Ohnishi K, Tagami M, Morii E, Azumi A. Topical Treatment for Orbital Capillary Hemangioma in an Adult Using a β-Blocker Solution. Case Rep Ophthalmol 2014;5:60-5. [PMID: 24707274 DOI: 10.1159/000360392] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
187 He X, Liu Y, Li K, Yang A, Wang R, Liu S. Sildenafil suppresses the proliferation and enhances the apoptosis of hemangioma endothelial cells. Exp Ther Med 2017;13:2645-50. [PMID: 28587325 DOI: 10.3892/etm.2017.4306] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
188 Moss C, Shahidullah H. Naevi and other Developmental Defects. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. Oxford: Wiley-Blackwell; 2010. pp. 1-107. [DOI: 10.1002/9781444317633.ch18] [Cited by in Crossref: 14] [Article Influence: 1.2] [Reference Citation Analysis]
189 Ji Y, Chen S, Xiang B, Yang Y, Qiu L. Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study. Sci Rep 2017;7:1503. [PMID: 28473717 DOI: 10.1038/s41598-017-01321-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
190 Baetz J, Eigelshoven S, Marquard J, Bruch-Gerharz D, Homey B, Meissner T. [Infantile hemangioma. Successful treatment with propranolol]. Hautarzt 2010;61:290-2. [PMID: 20300720 DOI: 10.1007/s00105-010-1938-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
191 Low CM, Stokken JK. Typical Orbital Pathologies: Hemangioma. J Neurol Surg B Skull Base 2021;82:20-6. [PMID: 33777617 DOI: 10.1055/s-0040-1722633] [Reference Citation Analysis]
192 Marcoux S, Théorêt Y, Dubois J, Essouri S, Pincivy A, Coulombe J, McCuaig C, Powell J, Soulez G, Kleiber N. Systemic, local, and sclerotherapy drugs: What do we know about drug prescribing in vascular anomalies? Pediatr Blood Cancer 2021;68:e29364. [PMID: 34596969 DOI: 10.1002/pbc.29364] [Reference Citation Analysis]
193 Meng J, Li Z, Gu Q, Zhang J, Zhuang Q, Si Y, Zhang A. Propranolol intervention therapy for infants with facial hemangioma. Contemp Oncol (Pozn) 2012;16:432-4. [PMID: 23788923 DOI: 10.5114/wo.2012.31774] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
194 Lou Y, Peng WJ, Cao Y, Cao DS, Xie J, Li HH. The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies. Br J Clin Pharmacol. 2014;78:44-57. [PMID: 24033819 DOI: 10.1111/bcp.12235] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
195 Kuang X, Qi M, Peng C, Zhou C, Su J, Zeng W, Liu H, Zhang J, Chen M, Shen M, Xie X, Li F, Zhao S, Li Q, Luo Z, Chen J, Tao J, He Y, Chen X. Propranolol enhanced the anti-tumor effect of sunitinib by inhibiting proliferation and inducing G0/G1/S phase arrest in malignant melanoma. Oncotarget 2018;9:802-11. [PMID: 29416656 DOI: 10.18632/oncotarget.22696] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
196 Bramhall RJ, Gorman M, Holmes WJ, Haeney JA. Should we treat all haemangiomas with beta-blockers? J Plast Reconstr Aesthet Surg 2012;65:1126-7. [PMID: 22445032 DOI: 10.1016/j.bjps.2012.03.008] [Reference Citation Analysis]
197 Ramdhani D, Seedat RY. Recurrent parotid cavernous haemangioma in an adolescent, successfully treated with Propranolol. Eur Ann Otorhinolaryngol Head Neck Dis 2018;135:S117-9. [PMID: 30139696 DOI: 10.1016/j.anorl.2018.07.006] [Reference Citation Analysis]
198 Albiñana V, Cuesta AM, de Rojas-p I, Gallardo-vara E, Recio-poveda L, Bernabéu C, Botella LM. Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding. JCM 2020;9:1766. [DOI: 10.3390/jcm9061766] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
199 Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, Chun RH, Garzon MC, Holland KE, Liberman L. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131:128-140. [PMID: 23266923 DOI: 10.1542/peds.2012-1691] [Cited by in Crossref: 304] [Cited by in F6Publishing: 219] [Article Influence: 30.4] [Reference Citation Analysis]
200 Dong JY, Ning JX, Li K, Liu C, Wang XX, Li RH, Yue LL, Huang YY, Liu SH. Analysis of factors affecting the therapeutic effect of propranolol for infantile haemangioma of the head and neck. Sci Rep 2017;7:342. [PMID: 28336941 DOI: 10.1038/s41598-017-00495-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
201 Srinivas SM, Hiremagalore R, Venkataramaiah LD, Premalatha R. Pediatric dermatology inpatient consultations: a retrospective study. Indian J Pediatr 2015;82:541-4. [PMID: 25640068 DOI: 10.1007/s12098-015-1697-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
202 Dill PE, Liang N, Pende M. New insights into the pathophysiology of the tuberous sclerosis complex: Crosstalk of mTOR- and hippo-YAP pathways in cell growth. Rare Dis 2015;3:e1016701. [PMID: 26459669 DOI: 10.1080/21675511.2015.1016701] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
203 Shenoy J, Coutinho A, Kamath SP, Pai S, Rai SP. Neonatal Airway Compromise by a Giant Cervicothoracic Venous Haemangioma. J Clin Diagn Res 2017;11:SD01-2. [PMID: 28384953 DOI: 10.7860/JCDR/2017/23848.9406] [Reference Citation Analysis]
204 Dachlan I, Wahdini SI, Putri IL, Seswandhana MR, Wicaksana A, Fauzi AR. Integrated propranolol, methylprednisolone, and surgery in managing a rare case of infantile hemangioma with concurrent cleft lip and palate. Ann Med Surg (Lond) 2020;56:91-4. [PMID: 32612824 DOI: 10.1016/j.amsu.2020.06.015] [Reference Citation Analysis]
205 Filippi L, Cavallaro G, Fiorini P, Daniotti M, Benedetti V, Cristofori G, Araimo G, Ramenghi L, La Torre A, Fortunato P. Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491. BMC Pediatr. 2010;10:83. [PMID: 21087499 DOI: 10.1186/1471-2431-10-83] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
206 Mimura H, Akita S, Fujino A, Jinnin M, Ozaki M, Osuga K, Nakaoka H, Morii E, Kuramochi A, Aoki Y, Arai Y, Aramaki N, Inoue M, Iwashina Y, Iwanaka T, Ueno S, Umezawa A, Ozeki M, Ochi J, Kinoshita Y, Kurita M, Seike S, Takakura N, Takahashi M, Tachibana T, Chuman K, Nagata S, Narushima M, Niimi Y, Nosaka S, Nozaki T, Hashimoto K, Hayashi A, Hirakawa S, Fujikawa A, Hori Y, Matsuoka K, Mori H, Yamamoto Y, Yuzuriha S, Rikihisa N, Watanabe S, Watanabe S, Kuroda T, Sugawara S, Ishikawa K, Sasaki S. Japanese clinical practice guidelines for vascular anomalies 2017. Jpn J Radiol 2020;38:287-342. [PMID: 32207066 DOI: 10.1007/s11604-019-00885-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
207 Nagaraja AS, Sadaoui NC, Lutgendorf SK, Ramondetta LM, Sood AK. β-blockers: a new role in cancer chemotherapy? Expert Opin Investig Drugs 2013;22:1359-63. [PMID: 23919278 DOI: 10.1517/13543784.2013.825250] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
208 Kong HB, Zheng GY, He BM, Zhang Y, Zhou Q. Clinical Efficacy and Safety of Propranolol in the Prevention and Treatment of Retinopathy of Prematurity: A Meta-Analysis of Randomized Controlled Trials. Front Pediatr 2021;9:631673. [PMID: 33643978 DOI: 10.3389/fped.2021.631673] [Reference Citation Analysis]
209 Kelchen MN, Brogden NK. In Vitro Skin Retention and Drug Permeation through Intact and Microneedle Pretreated Skin after Application of Propranolol Loaded Microemulsions. Pharm Res 2018;35:228. [PMID: 30302631 DOI: 10.1007/s11095-018-2495-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
210 Lin Z, Wang L, Huang G, Wang W, Lin H. Propranolol inhibits the activity of PI3K, AKT, and HIF-1α in infantile hemangiomas. Pediatr Surg Int 2018;34:1233-8. [PMID: 30232552 DOI: 10.1007/s00383-018-4347-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
211 De Lellis L, Veschi S, Tinari N, Mokini Z, Carradori S, Brocco D, Florio R, Grassadonia A, Cama A. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. Cancers (Basel) 2021;13:3946. [PMID: 34439102 DOI: 10.3390/cancers13163946] [Reference Citation Analysis]
212 Bi S, Chen S, Wu B, Cen Y, Chen J. The Effectiveness of Different Treatment Modalities of Cutaneous Angiosarcoma: Results From Meta-Analysis and Observational Data From SEER Database. Front Oncol 2021;11:627113. [PMID: 33718199 DOI: 10.3389/fonc.2021.627113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 Blatt J, Farag S, Corey SJ, Sarrimanolis Z, Muratov E, Fourches D, Tropsha A, Janzen WP. Expanding the scope of drug repurposing in pediatrics: the Children's Pharmacy Collaborative. Drug Discov Today 2014;19:1696-8. [PMID: 25149597 DOI: 10.1016/j.drudis.2014.08.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
214 Liang N, Pende M. YAP enters the mTOR pathway to promote tuberous sclerosis complex. Mol Cell Oncol 2015;2:e998100. [PMID: 27308518 DOI: 10.1080/23723556.2014.998100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
215 Hudalla H, Bruckner T, Pöschl J, Strowitzki T, Kuon RJ. Antenatal exposure to fenoterol is not associated with the development of retinopathy of prematurity in infants born before 32 weeks of gestation. Arch Gynecol Obstet 2020;301:687-92. [PMID: 32112180 DOI: 10.1007/s00404-020-05463-z] [Reference Citation Analysis]
216 Yu L, Wei L, Xu Z, Zhang B, Han X, Sun Y, Liu Y, Wang C, Qiu L, Xiu B, He R, Li L, Ma L. Safety assessment of propranolol for infantile hemangioma: a study in an Asian population. Expert Rev Clin Pharmacol 2021;:1-6. [PMID: 34918994 DOI: 10.1080/17512433.2022.2020638] [Reference Citation Analysis]
217 Annabi B, Vaillancourt-Jean E, Weil AG, Béliveau R. Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells. Onco Targets Ther 2010;3:219-26. [PMID: 21124749 DOI: 10.2147/OTT.S14503] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
218 Kardasevic M, Dinarevic SM. Infantile Sacral Region Hemangioma and Combination Treatment with Propranolol and Topical Timolol: Case Review and Reference Review. Med Arch 2021;75:158-61. [PMID: 34219878 DOI: 10.5455/medarh.2021.75.158-161] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Ainipully AM, Narayanan SK, Vazhiyodan AP, Somnath P. Oral Propranolol in Infantile Hemangiomas: Analysis of Factors that Affect the Outcome. J Indian Assoc Pediatr Surg 2019;24:170-5. [PMID: 31258264 DOI: 10.4103/jiaps.JIAPS_12_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
220 Zhang L, Wu HW, Yuan W, Zheng JW. Propranolol therapy for infantile hemangioma: our experience. Drug Des Devel Ther 2017;11:1401-8. [PMID: 28507428 DOI: 10.2147/DDDT.S134808] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
221 Wang X, Feng W, Zhao X, Liu Z, Dong L. The Efficacy and Safety of Topical β-Blockers in Treating Infantile Hemangiomas: A Meta-Analysis Including 11 Randomized Controlled Trials. Dermatology 2021;237:433-43. [PMID: 33027794 DOI: 10.1159/000510029] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
222 Bischoff J. Progenitor cells in infantile hemangioma. J Craniofac Surg 2009;20 Suppl 1:695-7. [PMID: 19169153 DOI: 10.1097/SCS.0b013e318193d6ac] [Cited by in Crossref: 36] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
223 Castaneda S, Melendez-Lopez S, Garcia E, De la Cruz H, Sanchez-Palacio J. The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol. Adv Ther 2016;33:1831-9. [PMID: 27461120 DOI: 10.1007/s12325-016-0391-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
224 Rossler L, Rothoeft T, Teig N, Koerner-Rettberg C, Deitmer T, Rieger CH, Hamelmann E. Ultrasound and colour Doppler in infantile subglottic haemangioma. Pediatr Radiol. 2011;41:1421-1428. [PMID: 21904830 DOI: 10.1007/s00247-011-2213-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
225 Harikrishna B, Ganesh A, Al-Zuahibi S, Al-Jabri S, Al-Waily A, Al-Riyami A, Al-Azri F, Masoud F, Al-Mujaini A. Oral propranolol for the treatment of periorbital infantile hemangioma: a preliminary report from oman. Middle East Afr J Ophthalmol 2011;18:298-303. [PMID: 22224018 DOI: 10.4103/0974-9233.90131] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
226 Ji Y, Chen S, Xiao X, Zheng S, Li K. β-blockers: a novel class of antitumor agents. Onco Targets Ther. 2012;5:391-401. [PMID: 23226026 DOI: 10.2147/ott.s38403] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
227 Sharma N, Bajpai M, Verma A, Panda SS, Singh AK. Masterly inactivity in infantile haemangioma: Does it still hold relevance? Afr J Paediatr Surg 2015;12:167-70. [PMID: 26612120 DOI: 10.4103/0189-6725.170181] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
228 Natawidjaja R, Ewen Wang N. Nonsurgical treatment of two cases of infantile facial growths in a resource-poor setting. Wilderness Environ Med 2015;26:91-3. [PMID: 25712300 DOI: 10.1016/j.wem.2014.08.002] [Reference Citation Analysis]
229 Fei Q, Lin Y, Chen X. Treatments for infantile Hemangioma: A systematic review and network meta-analysis.EClinicalMedicine. 2020;26:100506. [PMID: 33089121 DOI: 10.1016/j.eclinm.2020.100506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
230 de Graaf M, Totté JE, van Os-Medendorp H, van Renselaar W, Breugem CC, Pasmans SG. Treatment of Infantile Hemangioma in Regional Hospitals With eHealth Support: Evaluation of Feasibility and Acceptance by Parents and Doctors. JMIR Res Protoc 2014;3:e52. [PMID: 25367558 DOI: 10.2196/resprot.3418] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
231 Cawthorn TR, Fraulin FOG, Harrop AR. Infantile Hemangiomas of the Lip: Complications and Need for Surgical Intervention. Plast Reconstr Surg Glob Open 2019;7:e2308. [PMID: 31624693 DOI: 10.1097/GOX.0000000000002308] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
232 Aygünes U, Dogan MT, Keceli AM. PHACE Syndrome in a Child with Structural Malformations of the Brain. J Pediatr Genet 2021;10:315-8. [PMID: 34849278 DOI: 10.1055/s-0040-1714066] [Reference Citation Analysis]
233 Bangiyev JN, Gurgel R, Vanderhooft SL, Grimmer JF. Reversible profound sensorineural hearing loss due to propranolol sensitive hemangioma in an infant with PHACE syndrome. International Journal of Pediatric Otorhinolaryngology 2017;103:55-7. [DOI: 10.1016/j.ijporl.2017.10.006] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
234 Bertolini F, Sukhatme VP, Bouche G. Drug repurposing in oncology--patient and health systems opportunities. Nat Rev Clin Oncol 2015;12:732-42. [PMID: 26483297 DOI: 10.1038/nrclinonc.2015.169] [Cited by in Crossref: 152] [Cited by in F6Publishing: 142] [Article Influence: 21.7] [Reference Citation Analysis]
235 Stănciulescu MC, Popoiu MC, Cîmpean AM, David VL, Heredea R, Cerbu S, Boia ES. Expression of β1 adrenergic receptor in vascular anomalies in children. J Int Med Res 2021;49:3000605211047713. [PMID: 34590496 DOI: 10.1177/03000605211047713] [Reference Citation Analysis]
236 Lieb WE. [Tumors and tumor-like lesions of the orbit]. HNO 2010;58:661-71. [PMID: 20607507 DOI: 10.1007/s00106-010-2140-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
237 Aslam A, Griffiths CE. Drug therapies in dermatology. Clin Med (Lond) 2014;14:47-53. [PMID: 24532745 DOI: 10.7861/clinmedicine.14-1-47] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
238 Nip SY, Hon KL, Leung WK, Leung AK, Choi PC. Neonatal Abdominal Hemangiomatosis: Propranolol beyond Infantile Hemangioma. Case Rep Pediatr. 2016;2016:9803975. [PMID: 27110421 DOI: 10.1155/2016/9803975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
239 Massie J. Miracles in my time: Reflections of a pediatric respiratory physician. Pediatr Pulmonol 2021;56:3586-91. [PMID: 34553839 DOI: 10.1002/ppul.25693] [Reference Citation Analysis]
240 Hård AL, Hellström A. On the use of antiangiogenetic medications for retinopathy of prematurity. Acta Paediatr 2011;100:1063-5. [PMID: 21517962 DOI: 10.1111/j.1651-2227.2011.02330.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
241 Rodrigues WF, Miguel CB, Lazo-Chica JE, Trindade da Silva CA, Vieira CU, Clemente-Napimoga JT, Freire Oliveira CJ, Napimoga MH. Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade. J Indian Soc Periodontol 2019;23:511-6. [PMID: 31849395 DOI: 10.4103/jisp.jisp_77_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
242 Sethuraman G, Yenamandra VK, Gupta V. Management of infantile hemangiomas: current trends. J Cutan Aesthet Surg 2014;7:75-85. [PMID: 25136206 DOI: 10.4103/0974-2077.138324] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
243 Alcobia DC, Ziegler AI, Kondrashov A, Comeo E, Mistry S, Kellam B, Chang A, Woolard J, Hill SJ, Sloan EK. Visualizing Ligand Binding to a GPCR In Vivo Using NanoBRET. iScience 2018;6:280-8. [PMID: 30240618 DOI: 10.1016/j.isci.2018.08.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
244 Chen YZ, Bai N, Bi JH, Liu XW, Xu GQ, Zhang LF, Li XQ, Huo R. Propranolol inhibits the proliferation, migration and tube formation of hemangioma cells through HIF-1α dependent mechanisms. Braz J Med Biol Res 2017;50:e6138. [PMID: 28977119 DOI: 10.1590/1414-431X20176138] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
245 Strub GM, Kirsh AL, Whipple ME, Kuo WP, Keller RB, Kapur RP, Majesky MW, Perkins JA. Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma. JCI Insight 2016;1:e88856. [PMID: 27660822 DOI: 10.1172/jci.insight.88856] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
246 Anjum MZ, Pasha KH, Abbas SH, Zubair M. The outcome of combination of low dose oral prednisolone with propranolol for the treatment of infantile haemangioma. Pak J Med Sci 2016;32:211-4. [PMID: 27022377 DOI: 10.12669/pjms.321.6390] [Reference Citation Analysis]
247 Choeyprasert W, Natesirinilkul R, Charoenkwan P. Successful treatment of mild pediatric kasabach-merritt phenomenon with propranolol monotherapy. Case Rep Hematol 2014;2014:364693. [PMID: 24963423 DOI: 10.1155/2014/364693] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
248 Jain V, Roychoudhury S, Chadha R, Puri A. Variable response to propranolol therapy for infantile hemangiomas. Indian J Dermatol 2012;57:126-7. [PMID: 22615510 DOI: 10.4103/0019-5154.94281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
249 de Graaf M, Totte J, Breugem C, van Os-Medendorp H, Pasmans S. Evaluation of the Compliance, Acceptance, and Usability of a Web-Based eHealth Intervention for Parents of Children With Infantile Hemangiomas: Usability Study. JMIR Res Protoc 2013;2:e54. [PMID: 24345450 DOI: 10.2196/resprot.2897] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
250 El Hachem M, Gesualdo F, Diociaiuti A, Berti I, Vercellino N, Boccaletti V, Neri I, Porcedda G, Greco A, Carnevale C, Oranges T, Cutrone M, Dalmonte P. Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience. Ital J Pediatr 2017;43:40. [PMID: 28424095 DOI: 10.1186/s13052-017-0357-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
251 Ji Y, Chen S, Xiang B, Xu Z, Jiang X, Liu X, Wang Q, Lu G, Yang L. Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study. Sci Rep 2016;6:31744. [PMID: 27530723 DOI: 10.1038/srep31744] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
252 Moisan F, Oucherif S, Kaulanjan-Checkmodine P, Prey S, Rousseau B, Bonneu M, Claverol S, Gontier E, Lacomme S, Dousset L, Couffinhal T, Toutain J, Loot M, Cario-André M, Jullié ML, Léauté-Labrèze C, Taieb A, Rezvani HR. Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade. Proc Natl Acad Sci U S A 2021;118:e2018690118. [PMID: 33558238 DOI: 10.1073/pnas.2018690118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
253 Shepard MJ, Bugarini A, Edwards NA, Lu J, Zhang Q, Wu T, Zhuang Z, Chittiboina P. Repurposing propranolol as an antitumor agent in von Hippel-Lindau disease. J Neurosurg 2018;:1-9. [PMID: 30497198 DOI: 10.3171/2018.5.JNS172879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
254 Boye E, Olsen BR. Signaling mechanisms in infantile hemangioma. Curr Opin Hematol 2009;16:202-8. [PMID: 19367160 DOI: 10.1097/MOH.0b013e32832a07ff] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
255 Lee D, Boscolo E, Durham JT, Mulliken JB, Herman IM, Bischoff J. Propranolol targets the contractility of infantile haemangioma-derived pericytes. Br J Dermatol 2014;171:1129-37. [PMID: 24720697 DOI: 10.1111/bjd.13048] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
256 Overman J, Fontaine F, Wylie-Sears J, Moustaqil M, Huang L, Meurer M, Chiang IK, Lesieur E, Patel J, Zuegg J, Pasquier E, Sierecki E, Gambin Y, Hamdan M, Khosrotehrani K, Andelfinger G, Bischoff J, Francois M. R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma. Elife 2019;8:e43026. [PMID: 31358114 DOI: 10.7554/eLife.43026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
257 Munabi NC, England RW, Edwards AK, Kitajewski AA, Tan QK, Weinstein A, Kung JE, Wilcox M, Kitajewski JK, Shawber CJ, Wu JK. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation. Stem Cells Transl Med 2016;5:45-55. [PMID: 26574555 DOI: 10.5966/sctm.2015-0076] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
258 Albiñana V, Villar Gómez de Las Heras K, Serrano-Heras G, Segura T, Perona-Moratalla AB, Mota-Pérez M, de Campos JM, Botella LM. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients. Orphanet J Rare Dis 2015;10:118. [PMID: 26394686 DOI: 10.1186/s13023-015-0343-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
259 Ding Q, Tian XG, Li Y, Wang QZ, Zhang CQ. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway. World J Gastroenterol 2015; 21(32): 9566-9576 [PMID: 26327764 DOI: 10.3748/wjg.v21.i32.9566] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
260 Rao A, Ramam M. The case for case reports. Indian Dermatol Online J 2014;5:413-5. [PMID: 25396121 DOI: 10.4103/2229-5178.142480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
261 Chung SH, Park DH, Jung HL, Shim JW, Kim DS, Shim JY, Park MS, Koo HH. Successful and safe treatment of hemangioma with oral propranolol in a single institution. Korean J Pediatr 2012;55:164-70. [PMID: 22670151 DOI: 10.3345/kjp.2012.55.5.164] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
262 Anger J, Oliveira EM, Gabel J. EFFECTIVENESS OF FIXED DOSES OF PROPRANOLOL IN THE TREATMENT OF HEMANGIOMAS REGARDLESS OF CHILD'S WEIGHT GAIN: A CASE REPORT. Rev Paul Pediatr 2019;37:392-5. [PMID: 31090848 DOI: 10.1590/1984-0462/;2019;37;3;00004] [Reference Citation Analysis]
263 Cai Y, Lv F, Kaldybayeva N, Zhamilya A, Wu Z, Wu Y. 15, 16-Dihydrotanshinone I Inhibits Hemangiomas through Inducing Pro-apoptotic and Anti-angiogenic Mechanisms in Vitro and in Vivo. Front Pharmacol. 2018;9:25. [PMID: 29441017 DOI: 10.3389/fphar.2018.00025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
264 Patnaik SK, Sondhi V. Treating subglottic haemangioma with methylprednisolone and interferonα-2a. BMJ Case Rep 2009;2009:bcr11. [PMID: 21686412 DOI: 10.1136/bcr.11.2008.1214] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
265 Del Frari L, Léauté-Labrèze C, Guibaud L, Barbarot S, Lacour JP, Chaumont C, Delarue A, Voisard JJ, Brunner V. Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations. Pharmacol Res Perspect 2018;6:e00399. [PMID: 29736244 DOI: 10.1002/prp2.399] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
266 Xiao Q, Li Q, Zhang B, Yu W. Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence. Pediatr Surg Int 2013;29:575-81. [PMID: 23519547 DOI: 10.1007/s00383-013-3283-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
267 Wagner MJ, Ravi V, Menter DG, Sood AK. Endothelial cell malignancies: new insights from the laboratory and clinic. NPJ Precis Oncol 2017;1:11. [PMID: 29872699 DOI: 10.1038/s41698-017-0013-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
268 Parapatt GK, Oranges T, Paolantonio G, Ravà L, Giancristoforo S, Diociaiuti A, Hachem ME, Rollo M. Color Doppler Evaluation of Arterial Resistive Index in Infantile Hemangioma: A Useful Parameter to Monitor the Response to Oral Propranolol? Front Pediatr 2021;9:718135. [PMID: 34950614 DOI: 10.3389/fped.2021.718135] [Reference Citation Analysis]
269 Gajbhiye V, Nath S, Chatterjee S, De A, Ghosh D, Das SK. Role of propranolol in hemangiomas. J Indian Assoc Pediatr Surg 2011;16:173-4. [PMID: 22121324 DOI: 10.4103/0971-9261.86892] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
270 Biswas A, Clark EC, Sen CK, Gordillo GM. Phytochemical Inhibition of Multidrug Resistance Protein-1 as a Therapeutic Strategy for Hemangioendothelioma. Antioxid Redox Signal 2017;26:1009-19. [PMID: 27706944 DOI: 10.1089/ars.2016.6881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
271 Lagrèze WA, Rössler J, Illerhaus G, Maier W, Grosu A. [Therapy of tumors of the anterior orbit]. Ophthalmologe 2011;108:519-30. [PMID: 21598054 DOI: 10.1007/s00347-010-2191-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
272 Luong Kv, Nguyen LT. The role of β-adrenergic blockers in Parkinson's disease: possible genetic and cell-signaling mechanisms. Am J Alzheimers Dis Other Demen 2013;28:306-17. [PMID: 23695225 DOI: 10.1177/1533317513488919] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
273 Kim JS, Chandler A, Borzykowski R, Thornhill B, Taragin BH. Maximizing time-resolved MRA for differentiation of hemangiomas, vascular malformations and vascularized tumors. Pediatr Radiol 2012;42:775-84. [PMID: 22398688 DOI: 10.1007/s00247-012-2359-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
274 Gondi JT, Gazula S, Rajasekhar A, Usharani G. Excellent response of infantile orofacio-orbital hemangioma to propranolol-pictorial depiction and literature review. Contemp Clin Dent 2016;7:269-72. [PMID: 27307684 DOI: 10.4103/0976-237X.183060] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
275 Tu JB, Ma RZ, Dong Q, Jiang F, Hu XY, Li QY, Pattar P, Zhang H. Induction of apoptosis in infantile hemangioma endothelial cells by propranolol. Exp Ther Med. 2013;6:574-578. [PMID: 24137229 DOI: 10.3892/etm.2013.1159] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
276 Baluk P, Yao LC, Flores JC, Choi D, Hong YK, McDonald DM. Rapamycin reversal of VEGF-C-driven lymphatic anomalies in the respiratory tract. JCI Insight. 2017;2. [PMID: 28814666 DOI: 10.1172/jci.insight.90103] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
277 Sun X, Liu X, Lu N, Yao S, Xu X, Niu L. Short-term curative effect and safety of propranolol combined with laser in the treatment of infantile hemangiomas. Oncol Lett 2018;16:6561-5. [PMID: 30405795 DOI: 10.3892/ol.2018.9493] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
278 Sasaki M, North PE, Elsey J, Bubley J, Rao S, Jung Y, Wu S, Zou MH, Pollack BP, Kumar J, Singh H, Arbiser JL. Propranolol exhibits activity against hemangiomas independent of beta blockade. NPJ Precis Oncol 2019;3:27. [PMID: 31701018 DOI: 10.1038/s41698-019-0099-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
279 You Y, Li Y, Xiao Y, Zhang J. Propranolol vs. steroids in the treatment of infantile hemangiomas: A meta-analysis. Mol Clin Oncol 2021;15:156. [PMID: 34178327 DOI: 10.3892/mco.2021.2318] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Zhang L, Zheng JW, Yuan WE. Treatment of alarming head and neck infantile hemangiomas with interferon-α2a: a clinical study in eleven consecutive patients. Drug Des Devel Ther 2015;9:723-7. [PMID: 25678777 DOI: 10.2147/DDDT.S67682] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
281 Zhu Y, Tuerxun A, Hui Y, Abliz P. Effects of propranolol and isoproterenol on infantile hemangioma endothelial cells in vitro.. Exp Ther Med 2014;8:647-51. [PMID: 25009634 DOI: 10.3892/etm.2014.1780] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
282 Phillips JD, Merrill T, Gardner JR, Thomas Collins R 2nd, Sanchez J, Johnson AB, Eble BK, Hartzell LD, Kincannon JM, Richter GT. Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas. Int J Pediatr 2021;2021:6657796. [PMID: 33679994 DOI: 10.1155/2021/6657796] [Reference Citation Analysis]
283 Albiñana V, Escribano RMJ, Soler I, Padial LR, Recio-Poveda L, Villar Gómez de Las Heras K, Botella LM. Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease. Orphanet J Rare Dis 2017;12:122. [PMID: 28662711 DOI: 10.1186/s13023-017-0664-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
284 Hong P, Tammareddi N, Walvekar R, Chiu ES, Poole JC, Kluka EA, Simon LM. Successful discontinuation of propranolol for infantile hemangiomas of the head and neck at 12 months of age. Int J Pediatr Otorhinolaryngol 2013;77:1194-7. [PMID: 23706952 DOI: 10.1016/j.ijporl.2013.04.038] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
285 España A, Ornilla E, Panizo C. Rituximab en dermatología. Actas Dermo-Sifiliográficas 2013;104:380-92. [DOI: 10.1016/j.ad.2012.02.008] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
286 Lou H, Xu G, Huo R. Curative effect and safety of propranolol combined with prednisone in the treatment of infantile hemangiomas. Exp Ther Med 2018;15:4677-82. [PMID: 29805486 DOI: 10.3892/etm.2018.6035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
287 Spiteri Cornish K, Reddy AR. The use of propranolol in the management of periocular capillary haemangioma--a systematic review. Eye (Lond) 2011;25:1277-83. [PMID: 21738233 DOI: 10.1038/eye.2011.164] [Cited by in Crossref: 39] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
288 Tangtatco JA, Freedman C, Phillips J, Pope E. Surgical treatment outcomes of infantile hemangioma in children: Does prior medical treatment matter. Pediatr Dermatol 2018;35:e418-9. [PMID: 30187523 DOI: 10.1111/pde.13658] [Reference Citation Analysis]
289 Benvenisti H, Ben-Sira L, Constantini S, Roth J. Giant cranial and cerebellar hemangioma treated with propranolol. Childs Nerv Syst 2015;31:805-8. [PMID: 25472450 DOI: 10.1007/s00381-014-2603-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
290 Apra C, Dumot C, Bourdillon P, Pelissou-Guyotat I. Could propranolol be beneficial in adult cerebral cavernous malformations? Neurosurg Rev 2019;42:403-8. [PMID: 30610500 DOI: 10.1007/s10143-018-01074-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
291 Amaya CN, Perkins M, Belmont A, Herrera C, Nasrazadani A, Vargas A, Khayou T, Montoya A, Ballou Y, Galvan D, Rivas A, Rains S, Patel L, Ortega V, Lopez C, Chow W, Dickerson EB, Bryan BA. Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma. Oncoscience 2018;5:109-19. [PMID: 29854879 DOI: 10.18632/oncoscience.413] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
292 Cotter C, Solman L, Flohr C. A national audit of oral propranolol for the treatment of infantile haemangiomas. Br J Dermatol 2021. [PMID: 34473344 DOI: 10.1111/bjd.20738] [Reference Citation Analysis]
293 Giese RA, Turner M, Cleves M, Gardner JR, Richter GT. Propranolol for Treatment of Infantile Hemangioma: Efficacy and Effect on Pediatric Growth and Development. Int J Pediatr 2021;2021:6669383. [PMID: 33927773 DOI: 10.1155/2021/6669383] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
294 Kreshanti P, Putri NT, Martin VJ, Sukasah CL. The effectiveness of oral propranolol for infantile hemangioma on the head and neck region: A case series. Int J Surg Case Rep 2021;84:106120. [PMID: 34216913 DOI: 10.1016/j.ijscr.2021.106120] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Khunger N. The dynamics and power of change: changing practices in cutaneous and aesthetic surgery. J Cutan Aesthet Surg 2014;7:73-4. [PMID: 25136205 DOI: 10.4103/0974-2077.138323] [Reference Citation Analysis]
296 Chelleri C, Monzani NA, Gelmetti C, Milani GP, Fossali EF, Galeone C, Cavalli R. Residual Lesions After Pharmacological and Dye-Laser Treatment of Infantile Hemangiomas: Critical Review of 432 Cases. Lasers Surg Med 2020;52:597-603. [PMID: 31828809 DOI: 10.1002/lsm.23205] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
297 Kum JJ, Khan ZA. Mechanisms of propranolol action in infantile hemangioma. Dermatoendocrinol 2014;6:e979699. [PMID: 26413184 DOI: 10.4161/19381980.2014.979699] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
298 Liu Z, Yeo YH, Jackson C, Trimble K. Treatment failure with propranolol for subglottic haemangioma. BMJ Case Rep 2019;12:e227135. [PMID: 31088811 DOI: 10.1136/bcr-2018-227135] [Reference Citation Analysis]
299 V P, Puppala N, Deshmukh SN, B J, S A. Cavernous hemangioma of tongue: management of two cases. J Clin Diagn Res 2014;8:ZD15-7. [PMID: 25478463 DOI: 10.7860/JCDR/2014/10216.5005] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
300 Chalhoub G, Ayoub N. Traitement de l’érythème pudique par le carvédilol. Annales de Dermatologie et de Vénéréologie 2020;147:879-80. [DOI: 10.1016/j.annder.2020.07.005] [Reference Citation Analysis]
301 Wu S, Wang B, Chen L, Xiong S, Zhuang F, Huang X, Wang M, Huang Z. Clinical efficacy of propranolol in the treatment of hemangioma and changes in serum VEGF, bFGF and MMP-9. Exp Ther Med 2015;10:1079-83. [PMID: 26622443 DOI: 10.3892/etm.2015.2650] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
302 Liu X, Qu X, Zheng J, Zhang L. Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis. PLoS One 2015;10:e0138100. [PMID: 26375455 DOI: 10.1371/journal.pone.0138100] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
303 Kim KH, Choi TH, Choi Y, Park YW, Hong KY, Kim DY, Choe YS, Lee H, Cheon JE, Park JB, Park KD, Kang HJ, Shin HY, Jeong JH. Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial. JAMA Dermatol 2017;153:529-36. [PMID: 28423174 DOI: 10.1001/jamadermatol.2017.0250] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
304 Belen B, Oguz A, Okur A, Dalgic B. A complication to be aware of: hyperkalaemia following propranolol therapy for an infant with intestinal haemangiomatozis. BMJ Case Rep 2014;2014:bcr2014203746. [PMID: 24842358 DOI: 10.1136/bcr-2014-203746] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
305 Martin K, Blei F, Chamlin SL, Chiu YE, Frieden IJ, Frommelt PC, Garzon MC, Kwon EK, MacLellan-Tobert S, Mancini AJ, Seefeldt M, Sidbury R, Siegel DH, Drolet BA, Boucek RJ. Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers. Pediatr Dermatol 2013;30:155-9. [PMID: 23316721 DOI: 10.1111/pde.12022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
306 Huang L, Nakayama H, Klagsbrun M, Mulliken JB, Bischoff J. Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells. Stem Cells 2015;33:133-45. [PMID: 25187207 DOI: 10.1002/stem.1841] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
307 Andorfer KEC, Seebauer CT, Koller M, Zeman F, Berneburg M, Fischer R, Vielsmeier V, Bohr C, Kühnel TS. TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial. Clin Hemorheol Microcirc 2021. [PMID: 34864649 DOI: 10.3233/CH-211253] [Reference Citation Analysis]
308 Mantadakis E, Tsouvala E, Deftereos S, Danielides V, Chatzimichael A. Involution of a large parotid hemangioma with oral propranolol: an illustrative report and review of the literature. Case Rep Pediatr 2012;2012:353812. [PMID: 23227404 DOI: 10.1155/2012/353812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
309 Pasquier E, Andre N, Trahair T, Kavallaris M. Reply: Comment on 'Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma'--β-blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs. Br J Cancer 2013;109:2024-5. [PMID: 23969728 DOI: 10.1038/bjc.2013.498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
310 Patel NJ, Bauman NM. How should propranolol be initiated for infantile hemangiomas: Inpatient versus outpatient?: Propranolol for Infantile Hemangiomas. The Laryngoscope 2014;124:1279-81. [DOI: 10.1002/lary.24363] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
311 Wolter JK, Wolter NE, Blanch A, Partridge T, Cheng L, Morgenstern DA, Podkowa M, Kaplan DR, Irwin MS. Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma. Oncotarget 2014;5:161-72. [PMID: 24389287 DOI: 10.18632/oncotarget.1083] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
312 Meyer D. Serendipity, the humble case report and modern health science challenges. Middle East Afr J Ophthalmol 2011;18:303-4. [PMID: 22224019 DOI: 10.4103/0974-9233.90132] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
313 Vohra V, Gupta P, Malik PK, Pathak A. Propranolol therapy in a case of capillary hemangioma. Oman J Ophthalmol 2015;8:191-3. [PMID: 26903730 DOI: 10.4103/0974-620X.169907] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
314 Lang F, Press UP. [Infantile hemangioma of the eyelid]. Ophthalmologe 2017;114:1171-80. [PMID: 29147770 DOI: 10.1007/s00347-017-0604-x] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
315 Woody MM, Levy ML, Weinfeld AB. Propranolol for Preoperative Management of a Large Infantile Hemangioma. Pediatr Dermatol 2016;33:e198-200. [DOI: 10.1111/pde.12850] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
316 Bly RA, Perkins J, Parikh SR. Can topical beta-blockers reduce the size of superficial infantile hemangiomas of the head and neck? Laryngoscope 2017;127:4-5. [PMID: 27808405 DOI: 10.1002/lary.26350] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
317 Tong S, Xu DP, Liu ZM, Du Y, Wang XK. Evaluation of the efficacy and safety of topical timolol maleate combined with oral propranolol treatment for parotid mixed infantile hemangiomas. Oncol Lett 2016;12:1806-10. [PMID: 27588127 DOI: 10.3892/ol.2016.4818] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
318 Yun YJ, Gyon YH, Yang S, Lee YK, Park J, Park M. A prospective study to assess the efficacy and safety of oral propranolol as first-line treatment for infantile superficial hemangioma. Korean J Pediatr 2015;58:484-90. [PMID: 26770224 DOI: 10.3345/kjp.2015.58.12.484] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
319 Praticò AD, Caraci F, Pavone P, Falsaperla R, Drago F, Ruggieri M. Propranolol: Effectiveness and Failure in Infantile Cutaneous Hemangiomas. Drug Saf Case Rep 2015;2:6. [PMID: 27747719 DOI: 10.1007/s40800-015-0009-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
320 Ji Y, Chen S, Li K, Li L, Xu C, Xiang B. Signaling pathways in the development of infantile hemangioma. J Hematol Oncol 2014;7:13. [PMID: 24479731 DOI: 10.1186/1756-8722-7-13] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 6.6] [Reference Citation Analysis]
321 Roberts N. Infantile haemangioma: harmless 'strawberry' or life-threatening vascular anomaly? Clin Med (Lond) 2009;9:385-9. [PMID: 19728520 DOI: 10.7861/clinmedicine.9-4-385] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
322 Naughton A, Ong AY, Hildebrand GD. Safe and Effective Treatment of Intracranial Infantile Hemangiomas with Beta-Blockers. Pediatr Rep 2021;13:347-56. [PMID: 34287374 DOI: 10.3390/pediatric13030043] [Reference Citation Analysis]
323 Hernandez JA, Chia A, Quah BL, Seah LL. Periocular capillary hemangioma: management practices in recent years. Clin Ophthalmol 2013;7:1227-32. [PMID: 23814460 DOI: 10.2147/OPTH.S39029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
324 Cubuk S, Uckan S, Ozdemir H, Taslica ZF, Bacanli D. The efficiency of propranolol on occurrence and development of 4-nitroquinoline 1-oxide-induced squamous cell carcinoma of the tongue in rats. J Oral Maxillofac Pathol 2020;24:400. [PMID: 33456259 DOI: 10.4103/jomfp.JOMFP_88_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
325 Wells DA, Winlaw DS. Commentary: Serendipity leads to a fresh idea for an old problem. J Thorac Cardiovasc Surg 2021:S0022-5223(21)01411-2. [PMID: 34657718 DOI: 10.1016/j.jtcvs.2021.10.001] [Reference Citation Analysis]
326 May JE, Liew SH. A new treatment pathway for propranolol use in infantile haemangiomas. Journal of Plastic, Reconstructive & Aesthetic Surgery 2014;67:e91-2. [DOI: 10.1016/j.bjps.2013.10.008] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
327 Alexander L, Chacko H. A Curious Case of Ear Necrosis Salvaged by a Composite Temporalis Flap: Conchal Cartilage Graft Reconstruction. Cureus 2021;13:e15653. [PMID: 34277246 DOI: 10.7759/cureus.15653] [Reference Citation Analysis]
328 Pasquier E, André N, Street J, Chougule A, Rekhi B, Ghosh J, Philip DSJ, Meurer M, MacKenzie KL, Kavallaris M, Banavali SD. Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study. EBioMedicine 2016;6:87-95. [PMID: 27211551 DOI: 10.1016/j.ebiom.2016.02.026] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 10.2] [Reference Citation Analysis]
329 Baker JG, Fromont C, Bruder M, Thompson KSJ, Kellam B, Hill SJ, Gardiner SM, Fischer PM. Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-Blockers. ACS Pharmacol Transl Sci 2020;3:737-48. [PMID: 32832874 DOI: 10.1021/acsptsci.0c00051] [Reference Citation Analysis]
330 Nair AG, George RJ, Natarajan S, Jain V. Topical timolol for the treatment of conjunctival pyogenic granulomas: Outcomes and effect on intraocular pressure. Indian J Ophthalmol 2020;68:2170-4. [PMID: 32971633 DOI: 10.4103/ijo.IJO_183_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
331 Thomson J, Greig A, Lloyd C, Morrison D, Flohr C. PHACE syndrome misdiagnosed as a port-wine stain. BMJ Case Rep 2015;2015:bcr2015209889. [PMID: 26177999 DOI: 10.1136/bcr-2015-209889] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
332 Rao AA, Naheedy JH, Chen JY, Robbins SL, Ramkumar HL. A clinical update and radiologic review of pediatric orbital and ocular tumors. J Oncol 2013;2013:975908. [PMID: 23577029 DOI: 10.1155/2013/975908] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
333 Tamez HM, Sobel R. Review of the Treatment of Periocular Infantile Hemangiomas With Beta Blockers. International Ophthalmology Clinics 2017;57:169-76. [DOI: 10.1097/iio.0000000000000147] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
334 Hara MR, Sachs BD, Caron MG, Lefkowitz RJ. Pharmacological blockade of a β(2)AR-β-arrestin-1 signaling cascade prevents the accumulation of DNA damage in a behavioral stress model. Cell Cycle. 2013;12:219-224. [PMID: 23287463 DOI: 10.4161/cc.23368] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
335 Fung AT, Tran T, Lim LL, Samarawickrama C, Arnold J, Gillies M, Catt C, Mitchell L, Symons A, Buttery R, Cottee L, Tumuluri K, Beaumont P. Local delivery of corticosteroids in clinical ophthalmology: A review. Clin Exp Ophthalmol 2020;48:366-401. [PMID: 31860766 DOI: 10.1111/ceo.13702] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
336 Saha J, Kim JH, Amaya CN, Witcher C, Khammanivong A, Korpela DM, Brown DR, Taylor J, Bryan BA, Dickerson EB. Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux. Front Oncol 2020;10:614288. [PMID: 33598432 DOI: 10.3389/fonc.2020.614288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
337 Alhayaza R, Khan SA, Semidey VA, Owaidhah O. The Effectiveness of Propranolol in Managing Hemorrhagic Choroidal and Exudative Retinal Detachment following Ahmed Glaucoma Valve Implantation in Sturge-Weber Syndrome: Case Report and Literature Review. Case Rep Ophthalmol 2021;12:859-69. [PMID: 34899259 DOI: 10.1159/000518805] [Reference Citation Analysis]
338 Gupta A, Kureel SN, Pandey A, Singh G, Kumar A, Shandilya G, Rai RK, Gupta SK. Angiotensin-converting Enzyme Inhibitors: Can it be a Potential Treatment of Infantile Hemangioma. J Indian Assoc Pediatr Surg 2021;26:234-9. [PMID: 34385766 DOI: 10.4103/jiaps.JIAPS_112_20] [Reference Citation Analysis]
339 Quốc Lu'o'ng KV, Nguyễn LT. The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms. Cancer Manag Res 2012;4:431-45. [PMID: 23293538 DOI: 10.2147/CMAR.S39153] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
340 Park M. Infantile hemangioma: timely diagnosis and treatment. Clin Exp Pediatr 2021;64:573-4. [PMID: 34325500 DOI: 10.3345/cep.2021.00752] [Reference Citation Analysis]
341 Makkeyah SM, Elseedawy ME, Abdel-Kader HM, Mokhtar GM, Ragab IA. Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma. Pediatr Hematol Oncol 2021;:1-10. [PMID: 34477031 DOI: 10.1080/08880018.2021.1961956] [Reference Citation Analysis]
342 Xu S, Dong Y, Jia R, Lin M, Ge S, Fan X. Early reconstruction surgery resolving visual occlusion and ocular malformation: a case report. Medicine (Baltimore) 2014;93:e253. [PMID: 25546665 DOI: 10.1097/MD.0000000000000253] [Reference Citation Analysis]
343 Zhu L, Xie J, Liu Z, Huang Z, Huang M, Yin H, Qi W, Yang Z, Zhou T, Gao G, Zhang J, Yang X. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol. Cancer Sci 2018;109:1981-94. [PMID: 29664206 DOI: 10.1111/cas.13611] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
344 Labau D, Cadic P, Ouroussoff G, Ligeron C, Laroche JP, Guillot B, Dereure O, Quéré I, Galanaud JP. [Therapeutic indications for percutaneous laser in patients with vascular malformations and tumors]. J Mal Vasc 2014;39:363-72. [PMID: 25086985 DOI: 10.1016/j.jmv.2014.06.001] [Reference Citation Analysis]
345 Vabres P. [What's new in pediatric dermatology?]. Ann Dermatol Venereol 2008;135 Suppl 7:S343-53. [PMID: 19264210 DOI: 10.1016/S0151-9638(08)75487-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
346 Shen M, Asawa R, Zhang YQ, Cunningham E, Sun H, Tropsha A, Janzen WP, Muratov EN, Capuzzi SJ, Farag S, Jadhav A, Blatt J, Simeonov A, Martinez NJ. Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. Oncotarget 2018;9:4758-72. [PMID: 29435139 DOI: 10.18632/oncotarget.23462] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
347 Lackner H, Karastaneva A, Schwinger W, Benesch M, Sovinz P, Seidel M, Sperl D, Lanz S, Haxhija E, Reiterer F, Sorantin E, Urban CE. Sirolimus for the treatment of children with various complicated vascular anomalies. Eur J Pediatr 2015;174:1579-84. [PMID: 26040705 DOI: 10.1007/s00431-015-2572-y] [Cited by in Crossref: 126] [Cited by in F6Publishing: 102] [Article Influence: 18.0] [Reference Citation Analysis]
348 Wilson M, Snyderman C. Endoscopic Management of Developmental Anomalies of the Skull Base. J Neurol Surg B Skull Base 2018;79:13-20. [PMID: 29404236 DOI: 10.1055/s-0037-1615815] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
349 Frongia G, Byeon JO, Arnold R, Mehrabi A, Günther P. Cardiac diagnostics before oral propranolol therapy in infantile hemangioma: retrospective evaluation of 234 infants. World J Pediatr 2018;14:254-8. [PMID: 29796952 DOI: 10.1007/s12519-018-0137-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
350 Erdağ TK. Do Case Reports Still Have a Place in Turkish Archives of Otorhinolaryngology? Turk Arch Otorhinolaryngol 2017;55:1-2. [PMID: 29392043 DOI: 10.5152/tao.2017.201701] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
351 Fraulin FO, Flannigan RK, Sharma VK, McPhalen DF, Harrop RA. The epidemiological profile of the Vascular Birthmark Clinic at the Alberta Children's Hospital. Can J Plast Surg 2012;20:67-70. [PMID: 23730152 DOI: 10.1177/229255031202000211] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
352 Sanz-Marco E, Gallego R, Diaz-Llopis M. Oral propranolol for circumscribed choroidal hemangioma. Case Rep Ophthalmol 2011;2:84-90. [PMID: 21475606 DOI: 10.1159/000325142] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
353 Sun LM, Xu Y, Xu MN, Wang M, Su Y, Yuan SM. Diagnosis and treatment of periorbital infantile hemangiomas: Case series and literature review. Int J Pediatr Otorhinolaryngol 2020;136:110157. [PMID: 32544638 DOI: 10.1016/j.ijporl.2020.110157] [Reference Citation Analysis]
354 Polymerou I, Ojala T, Bonou P, Martelius L, Tzifa A. Successful treatment of cardiac haemangiomas with oral propranolol: a case series of two patients. Eur Heart J Case Rep 2019;3:ytz093. [PMID: 31449646 DOI: 10.1093/ehjcr/ytz093] [Reference Citation Analysis]
355 Craiglow BG, Antaya RJ. Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches. Paediatr Drugs 2013;15:133-8. [PMID: 23456550 DOI: 10.1007/s40272-013-0008-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
356 Colmant C, Powell J. Medical Management of Infantile Hemangiomas: An Update. Paediatr Drugs 2021. [PMID: 34677814 DOI: 10.1007/s40272-021-00477-9] [Reference Citation Analysis]
357 Panditray S, Acharya S, Prusty N, Dany SS. Management of Head and Neck Hemangiomas in Adults: Oral Propranolol Versus Oral Itraconazole in Conjugation with Injection Sodium Tetra Decyl Sulphate. Indian J Otolaryngol Head Neck Surg 2019;71:566-73. [PMID: 31742022 DOI: 10.1007/s12070-018-1410-8] [Reference Citation Analysis]
358 Rains SL, Amaya CN, Bryan BA. Beta-adrenergic receptors are expressed across diverse cancers. Oncoscience 2017;4:95-105. [PMID: 28966942 DOI: 10.18632/oncoscience.357] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 7.6] [Reference Citation Analysis]
359 Tavakoli M, Yadegari S, Mosallaei M, Aletaha M, Salour H, Lee WW. Infantile Periocular Hemangioma. J Ophthalmic Vis Res 2017;12:205-11. [PMID: 28540013 DOI: 10.4103/jovr.jovr_66_17] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
360 Chen ZY, Wang QN, Zhu YH, Zhou LY, Xu T, He ZY, Yang Y. Progress in the treatment of infantile hemangioma. Ann Transl Med 2019;7:692. [PMID: 31930093 DOI: 10.21037/atm.2019.10.47] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
361 Callahan AB, Yoon MK. Infantile hemangiomas: A review. Saudi J Ophthalmol 2012;26:283-91. [PMID: 23961007 DOI: 10.1016/j.sjopt.2012.05.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
362 Cheng J, Liu B, Lee HJ. Outcomes of surgical treatment for hemangiomas. Pediatr Dermatol 2019;36:207-12. [PMID: 30793785 DOI: 10.1111/pde.13751] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
363 Li DJ, Romar GA, Hsieh PC, Wells M, Foreman RK, Lian CG, Divito SJ. Histologic features of graft-versus-host disease-associated angiomatosis: Insights into pathophysiology and treatment. J Am Acad Dermatol 2020;83:914-7. [PMID: 31923444 DOI: 10.1016/j.jaad.2019.12.058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
364 Letertre O, Boccara O, Prey S, Pedespan JM, Boralevi F, Léauté-Labrèze C. Segmental facial infantile haemangiomas in the era of propranolol: evaluation at 6 years of age. J Eur Acad Dermatol Venereol 2022. [PMID: 35000215 DOI: 10.1111/jdv.17907] [Reference Citation Analysis]
365 Boscolo E, Mulliken JB, Bischoff J. Pericytes from infantile hemangioma display proangiogenic properties and dysregulated angiopoietin-1. Arterioscler Thromb Vasc Biol 2013;33:501-9. [PMID: 23288163 DOI: 10.1161/ATVBAHA.112.300929] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
366 Lin Z, Zhang B, Yu Z, Li H. The effectiveness and safety of topical β-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies. Br J Clin Pharmacol 2020;86:199-209. [PMID: 31833573 DOI: 10.1111/bcp.14196] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
367 Reimer A, Ott H. [Infantile haemangioma: an update]. Hautarzt 2019;70:447-58. [PMID: 31101924 DOI: 10.1007/s00105-019-4404-x] [Reference Citation Analysis]
368 Murthy GJ, Goswami M. Management of adult onset orbital hemangioma by oral propranalol: a case report. Orbit 2012;31:373-5. [PMID: 22877318 DOI: 10.3109/01676830.2012.711891] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
369 Siegert R, Magritz R. Malformation and plastic surgery in childhood. GMS Curr Top Otorhinolaryngol Head Neck Surg 2014;13:Doc01. [PMID: 25587361 DOI: 10.3205/cto000104] [Reference Citation Analysis]
370 Hao J, Yang MB, Liu H, Li SK. Distribution of propranolol in periocular tissues: a comparison of topical and systemic administration. J Ocul Pharmacol Ther 2011;27:453-9. [PMID: 21810027 DOI: 10.1089/jop.2011.0055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
371 Itinteang T, Withers AH, Davis PF, Tan ST. Biology of infantile hemangioma. Front Surg. 2014;1:38. [PMID: 25593962 DOI: 10.3389/fsurg.2014.00038] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
372 Löffler H, Kosel C, Cremer H, Kachel W. [Propranolol therapy to treat problematic hemangiomas : a new standard therapy makes its debut]. Hautarzt 2009;60:1013-6. [PMID: 19859669 DOI: 10.1007/s00105-009-1856-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
373 Classen CF, Haffner D, Hauenstein C, Wolf R, Kyank U. Long-time octreotide in an adolescent with severe haemorrhagic gastrointestinal vascular malformation. BMJ Case Rep 2011;2011:bcr0520114291. [PMID: 22688939 DOI: 10.1136/bcr.05.2011.4291] [Reference Citation Analysis]
374 Zhao ZL, Liu C, Wang QZ, Wu HW, Zheng JW. Oral atenolol treatment for infantile hemangiomas: clinical analysis of 133 consecutive patients. Ann Transl Med 2021;9:116. [PMID: 33569418 DOI: 10.21037/atm-20-5359] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
375 Alexiou GA, Prodromou N, Moschovi M. Treatment of pediatric patients with cerebral cavernous malformation. J Clin Neurosci 2012;19:339. [PMID: 22209396 DOI: 10.1016/j.jocn.2011.10.002] [Reference Citation Analysis]
376 Bonner MY, Arbiser JL. Targeting NADPH oxidases for the treatment of cancer and inflammation. Cell Mol Life Sci 2012;69:2435-42. [PMID: 22581366 DOI: 10.1007/s00018-012-1017-2] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
377 Castaneda S, Garcia E, De la Cruz H, Ramirez O, Melendez S, Sanchez-Palacio J. Therapeutic Effect of Propranolol in Mexican Patients with Infantile Hemangioma. Drugs Real World Outcomes 2016;3:25-31. [PMID: 27747797 DOI: 10.1007/s40801-015-0052-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
378 Padia R, Bly R, Bull C, Geddis AE, Perkins J. Medical Management of Vascular Anomalies. Curr Treat Options Pediatr 2018;4:221-36. [PMID: 30505648 DOI: 10.1007/s40746-018-0130-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
379 Mimura H, Akita S, Fujino A, Jinnin M, Ozaki M, Osuga K, Nakaoka H, Morii E, Kuramochi A, Aoki Y, Arai Y, Aramaki N, Inoue M, Iwashina Y, Iwanaka T, Ueno S, Umezawa A, Ozeki M, Ochi J, Kinoshita Y, Kurita M, Seike S, Takakura N, Takahashi M, Tachibana T, Chuman K, Nagata S, Narushima M, Niimi Y, Nosaka S, Nozaki T, Hashimoto K, Hayashi A, Hirakawa S, Fujikawa A, Hori Y, Matsuoka K, Mori H, Yamamoto Y, Yuzuriha S, Rikihisa N, Watanabe S, Watanabe S, Kuroda T, Sugawara S, Ishikawa K, Sasaki S. Japanese clinical practice guidelines for vascular anomalies 2017. Pediatr Int 2020;62:257-304. [PMID: 32202048 DOI: 10.1111/ped.14077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
380 Schittkowski MP, Fichter N. [Orbital neoplasia. Part I: Introduction, vascular and neurogenic tumors]. Ophthalmologe 2012;109:1033-44; quiz 1045. [PMID: 23053338 DOI: 10.1007/s00347-012-2664-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
381 Burd A. Research in burns - Present and future. Indian J Plast Surg 2010;43:S11-4. [PMID: 21321644 DOI: 10.4103/0970-0358.70717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
382 Kilpatrick LE, Alcobia DC, White CW, Peach CJ, Glenn JR, Zimmerman K, Kondrashov A, Pfleger KDG, Ohana RF, Robers MB, Wood KV, Sloan EK, Woolard J, Hill SJ. Complex Formation between VEGFR2 and the β2-Adrenoceptor. Cell Chem Biol 2019;26:830-841.e9. [PMID: 30956148 DOI: 10.1016/j.chembiol.2019.02.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
383 Luca AC, Miron IC, Trandafir LM, Cojocaru E, Pădureţ IA, Trandafirescu MF, Iordache AC, Ţarcă E. Morphological, genetic and clinical correlations in infantile hemangiomas and their mimics. Rom J Morphol Embryol 2020;61:687-95. [PMID: 33817710 DOI: 10.47162/RJME.61.3.07] [Reference Citation Analysis]
384 Sendrasoa FA, Ranaivo IM, Razanakoto NH, Andrianarison M, Ramarozatovo LS, Rapelanoro Rabenja F. Excellent response of infantile orbital hemangioma to propranolol. Int Med Case Rep J 2016;9:369-71. [PMID: 27895515 DOI: 10.2147/IMCRJ.S122553] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
385 Meyer D, Gooding C. Intralesional Bleomycin as an Adjunct Therapeutic Modality in Eyelid and Extraocular Malignancies and Tumors. Middle East Afr J Ophthalmol 2015;22:410-4. [PMID: 26692709 DOI: 10.4103/0974-9233.167822] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
386 Tan X, Guo S, Wang C. Propranolol in the Treatment of Infantile Hemangiomas. Clin Cosmet Investig Dermatol 2021;14:1155-63. [PMID: 34511960 DOI: 10.2147/CCID.S332625] [Reference Citation Analysis]
387 Raufi N, Nemat A. Infantile Hemangioma Treated with Oral Propranolol: Case Presentation. Clin Cosmet Investig Dermatol 2021;14:1053-5. [PMID: 34471369 DOI: 10.2147/CCID.S326794] [Reference Citation Analysis]
388 Li X, Ma C, Xu J, Gao B, Steele M, Idris A. Elevated eosinophil levels observed in infantile hemangioma patients from Kaifeng, China. F1000Res 2019;8:2111. [PMID: 32047605 DOI: 10.12688/f1000research.21608.1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
389 Hildebrand GD, Sipkova Z. Topical Timolol for Infantile Haemangioma of the Orbit. Klin Monbl Augenheilkd 2021;238:1069-76. [PMID: 34662921 DOI: 10.1055/a-1645-1665] [Reference Citation Analysis]
390 Hoffman JE, Ryan M, Wittenberg B, Armstrong J, Greenan K, Wilkinson C. Successful treatment of hemorrhagic brainstem cavernous malformation with hematoma evacuation and postoperative propranolol. Childs Nerv Syst 2020;36:2109-12. [PMID: 32303833 DOI: 10.1007/s00381-020-04588-5] [Reference Citation Analysis]
391 Eivazi B, Werner JA. Extracranial vascular malformations (hemangiomas and vascular malformations) in children and adolescents - diagnosis, clinic, and therapy. GMS Curr Top Otorhinolaryngol Head Neck Surg 2014;13:Doc02. [PMID: 25587362 DOI: 10.3205/cto000105] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
392 Jungbauer F, Gvaramia D, Huber L, Kramer B, Ponto KA, Popovic Z, Riffel P, Rotter N, Scherl C, Zaubitzer L, Lammert A. [Differential diagnosis of intraorbital masses - a narrative review]. Laryngorhinootologie 2021. [PMID: 34902864 DOI: 10.1055/a-1580-7371] [Reference Citation Analysis]
393 Janmohamed SR, Madern GC, de Laat PC, Oranje AP. Educational paper: therapy of infantile haemangioma--history and current state (part II). Eur J Pediatr. 2015;174:259-266. [PMID: 25178895 DOI: 10.1007/s00431-014-2404-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
394 Metry D, Frieden IJ, Hess C, Siegel D, Maheshwari M, Baselga E, Chamlin S, Garzon M, Mancini AJ, Powell J, Drolet BA. Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol 2013;30:71-89. [PMID: 22994362 DOI: 10.1111/j.1525-1470.2012.01879.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
395 Dinulos JG. Drug discovery favors simple observation of the prepared mind. Curr Opin Pediatr 2013;25:471-3. [PMID: 23695718 DOI: 10.1097/MOP.0b013e328361c9fe] [Reference Citation Analysis]
396 Koh M, Takahashi T, Kurokawa Y, Kobayashi T, Saito T, Ishida T, Serada S, Fujimoto M, Naka T, Wada N, Yamashita K, Tanaka K, Miyazaki Y, Makino T, Nakajima K, Yamasaki M, Eguchi H, Doki Y. Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosis. Gastric Cancer 2021;24:1037-49. [PMID: 33782804 DOI: 10.1007/s10120-021-01184-7] [Reference Citation Analysis]
397 Padula C, Nicoli S, Pescina S, Santi P. The Influence of Formulation and Excipients on Propranolol Skin Permeation and Retention. Biomed Res Int 2018;2018:1281673. [PMID: 30175113 DOI: 10.1155/2018/1281673] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
398 Xu SQ, Jia RB, Zhang W, Zhu H, Ge SF, Fan XQ. Beta-blockers versus corticosteroids in the treatment of infantile hemangioma: an evidence-based systematic review. World J Pediatr. 2013;9:221-229. [PMID: 23929254 DOI: 10.1007/s12519-013-0427-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
399 Duarte D, Vale N. Combining repurposed drugs to treat colorectal cancer. Drug Discov Today 2021:S1359-6446(21)00406-2. [PMID: 34592446 DOI: 10.1016/j.drudis.2021.09.012] [Reference Citation Analysis]
400 Elajmi A, Clapuyt P, Hammer F, Bataille AC, Lengele B, Boon LM. [Management of vascular anomalies in children]. Ann Chir Plast Esthet 2016;61:480-97. [PMID: 27641115 DOI: 10.1016/j.anplas.2016.06.015] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
401 Nourinia R, Rezaei Kanavi M, Kaharkaboudi A, Taghavi SI, Aldavood SJ, Darjatmoko SR, Wang S, Gurel Z, Lavine JA, Safi S, Ahmadieh H, Daftarian N, Sheibani N. Ocular Safety of Intravitreal Propranolol and Its Efficacy in Attenuation of Choroidal Neovascularization. Invest Ophthalmol Vis Sci 2015;56:8228-35. [PMID: 26720475 DOI: 10.1167/iovs.15-17169] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
402 Leavitt DA, Hottinger DG, Reed RC, Shukla AR. A case series of genital vascular anomalies in children and their management: lessons learned. Urology 2012;80:914-8. [PMID: 22951002 DOI: 10.1016/j.urology.2012.06.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]